
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.1c31f4d4c46e.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.3c558ec9f8de.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.5c2920216256.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.6539a0a78536cfdc1fa6.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.e622fd8870cb011febf1.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD568A678924B500003BE6F1527366.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="1.4.0.post1+1040be0" />

<meta name="ncbi_domain" content="nihpa" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC7855004/" />


    


        <script>
            
            var useOfficialGovtHeader = true;
        </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855004/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Psychological medicine" /><meta name="citation_title" content="Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis" /><meta name="citation_author" content="Simon B. Goldberg" /><meta name="citation_author_institution" content="Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA" /><meta name="citation_author" content="Benjamin Shechet" /><meta name="citation_author_institution" content="Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA" /><meta name="citation_author" content="Christopher Nicholas" /><meta name="citation_author_institution" content="Department of Family Medicine and Community Health, University of Wisconsin - Madison, Madison, WI, USA" /><meta name="citation_author" content="Chi Wing Ng" /><meta name="citation_author_institution" content="Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA" /><meta name="citation_author" content="Geetanjali Deole" /><meta name="citation_author_institution" content="Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA" /><meta name="citation_author" content="Zhuofan Chen" /><meta name="citation_author_institution" content="Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA" /><meta name="citation_author" content="Charles Raison" /><meta name="citation_author_institution" content="School of Human Ecology, University of Wisconsin &#x02013; Madison, Madison, WI, USA" /><meta name="citation_author_institution" content="Usona Institute, Fitchberg, WI, USA" /><meta name="citation_publication_date" content="2020/12" /><meta name="citation_issue" content="16" /><meta name="citation_volume" content="50" /><meta name="citation_firstpage" content="2655" /><meta name="citation_doi" content="10.1017/S003329172000389X" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC7855004/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC7855004/" /><meta name="citation_pmid" content="33143790" /><meta name="DC.Title" content="Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Simon B. Goldberg" /><meta name="DC.Contributor" content="Benjamin Shechet" /><meta name="DC.Contributor" content="Christopher Nicholas" /><meta name="DC.Contributor" content="Chi Wing Ng" /><meta name="DC.Contributor" content="Geetanjali Deole" /><meta name="DC.Contributor" content="Zhuofan Chen" /><meta name="DC.Contributor" content="Charles Raison" /><meta name="DC.Date" content="2020 Dec" /><meta name="DC.Identifier" content="10.1017/S003329172000389X" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis" /><meta property="og:type" content="article" /><meta property="og:description" content="Scientific interest in the therapeutic effects of classical psychedelics has increased in the past two decades. The psychological effects of these substances outside the period of acute intoxication have not been fully characterized. This study aimed ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855004/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
    


    
        <section class="pmc-alerts">

</section>
    

    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7855004
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pubreader-link other_item"><a href="/pmc/articles/PMC7855004/?report=reader" class="sidefm-pmclink">PubReader</a></li>
<li class="pdf-link other_item"><a href="/pmc/articles/PMC7855004/pdf/nihms-1635180.pdf" class="int-view">PDF (429K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7855004/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7855004/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<div class="collections-button-container" data-article-id="7855004" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7855004%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="DHzYSrE6roowqANOSGwMf1ycnWu5qmxOQKHLAbVMei7hCs3WcccdtuY0J2OaTADS">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7855004%2F&amp;text=Post-acute%20psychological%20effects%20of%20classical%20serotonergic%20psychedelics%3A%20A%20systematic%20review%20and%20meta-analysis" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7855004%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855004/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7855004/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/33143790/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7855004/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/33143790/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7855004/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7855004/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7855004
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">
        Learn more about our disclaimer.
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area target="_blank" rel="noopener noreferrer" shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div><span id="pmcmata">Psychol Med.</span> Author manuscript; available in PMC 2021 Jun 1.</div><div></div><div class="final-form"><em>Published in final edited form as:</em></div><div class="final-citation"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=33143790" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Psychol Med. 2020 Dec; 50(16): 2655–2666. </a></div><span class="fm-vol-iss-date">Published online 2020 Nov 4. </span> <span class="doi"><span>doi: </span><a href="//doi.org/10.1017%2FS003329172000389X" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1017/S003329172000389X</a></span></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC7855004</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS1635180</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33143790">33143790</a></div></div></div><h1 class="content-title">Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Goldberg%20SB%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131358089392" co-class="co-affbox">Simon B. Goldberg</a>,<sup>1,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shechet%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131358087440" co-class="co-affbox">Benjamin Shechet</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nicholas%20C%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131409469328" co-class="co-affbox">Christopher Nicholas</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ng%20CW%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131409467248" co-class="co-affbox">Chi Wing Ng</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Deole%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131409465168" co-class="co-affbox">Geetanjali Deole</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131409463136" co-class="co-affbox">Zhuofan Chen</a>,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Raison%20C%5BAuthor%5D" class="affpopup" co-rid="_co_idm140131359747792" co-class="co-affbox">Charles Raison</a><sup>3,</sup><sup>4</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140131358089392"><h3 class="no_margin">Simon B. Goldberg</h3><p><sup>1</sup>Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Goldberg%20SB%5BAuthor%5D">Simon B. Goldberg</a></div></div><div id="_co_idm140131358087440"><h3 class="no_margin">Benjamin Shechet</h3><p><sup>1</sup>Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shechet%20B%5BAuthor%5D">Benjamin Shechet</a></div></div><div id="_co_idm140131409469328"><h3 class="no_margin">Christopher Nicholas</h3><p><sup>2</sup>Department of Family Medicine and Community Health, University of Wisconsin - Madison, Madison, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nicholas%20C%5BAuthor%5D">Christopher Nicholas</a></div></div><div id="_co_idm140131409467248"><h3 class="no_margin">Chi Wing Ng</h3><p><sup>1</sup>Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ng%20CW%5BAuthor%5D">Chi Wing Ng</a></div></div><div id="_co_idm140131409465168"><h3 class="no_margin">Geetanjali Deole</h3><p><sup>1</sup>Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Deole%20G%5BAuthor%5D">Geetanjali Deole</a></div></div><div id="_co_idm140131409463136"><h3 class="no_margin">Zhuofan Chen</h3><p><sup>1</sup>Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20Z%5BAuthor%5D">Zhuofan Chen</a></div></div><div id="_co_idm140131359747792"><h3 class="no_margin">Charles Raison</h3><p><sup>3</sup>School of Human Ecology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</p><p><sup>4</sup>Usona Institute, Fitchberg, WI, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Raison%20C%5BAuthor%5D">Charles Raison</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140131408263696_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140131408263696_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140131408263696_ai" style="display:none"><div class="fm-affl" id="A1"><sup>1</sup>Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</div><div class="fm-affl" id="A2"><sup>2</sup>Department of Family Medicine and Community Health, University of Wisconsin - Madison, Madison, WI, USA</div><div class="fm-affl" id="A3"><sup>3</sup>School of Human Ecology, University of Wisconsin &#x02013; Madison, Madison, WI, USA</div><div class="fm-affl" id="A4"><sup>4</sup>Usona Institute, Fitchberg, WI, USA</div><div id="CR1"><sup>*</sup>Correspondence to: Simon B. Goldberg, Department of Counseling Psychology, University of Wisconsin &#x02013; Madison, 335 Education Building, 1000 Bascom Mall, Madison, WI, 53706 <a href="mailto:dev@null" data-email="ude.csiw@grebdlogbs" class="oemail">ude.csiw@grebdlogbs</a></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140131408263696_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm" role="complementary" aria-label="Related or updated information about this article."><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=33143790" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Psychol Med</a></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC7855004/bin/NIHMS1635180-supplement-1.pdf" data-ga-action="click_feat_suppl">NIHMS1635180-supplement-1.pdf</a><span style="color:gray"> (269K)</span></div><div class="small guid">GUID: 59F7C92F-1932-4C8D-B0D0-AFA54E28D158</div></div></dd></dl></div><div id="ABS1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="ABS1title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Background:</h3><p id="P1" class="p p-first-last">Scientific interest in the therapeutic effects of classical psychedelics has increased in the past two decades. The psychological effects of these substances outside the period of acute intoxication have not been fully characterized. This study aimed to: (1) quantify the effects of psilocybin, ayahuasca, and LSD on psychological outcomes in the post-acute period; (2) test moderators of these effects; and (3) evaluate adverse effects and risk of bias.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods:</h3><p id="P2" class="p p-first-last">We conducted a systematic review and meta-analysis of experimental studies (single-group pre-post or randomized controlled trials) that involved administration of psilocybin, ayahuasca, or LSD to clinical or non-clinical samples and assessed psychological outcomes &#x02265;24 hours post-administration. Effects were summarized by study design, timepoint, and outcome domain.</p></div><div id="S3" class="sec"><h3 id="S3title">Results:</h3><p id="P3" class="p p-first-last">A total of 34 studies (24 unique samples, <em>n</em> = 549, mean longest follow-up = 55.34 weeks) were included. Classical psychedelics showed significant within-group pre-post and between-group placebo-controlled effects on a range of outcomes including targeted symptoms within psychiatric samples, negative and positive affect-related measures, social outcomes, and existential/spiritual outcomes, with large between-group effect in these domains (Hedges&#x02019; <em>g</em>s = 0.84 to 1.08). Moderator tests suggest some effects may be larger in clinical samples. Evidence of effects on big five personality traits and mindfulness was weak. There was no evidence of post-acute adverse effects.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions:</h3><p id="P4" class="p p-first-last">High risk of bias in several domains, heterogeneity across studies, and indications of publication bias for some models highlight the need for careful, large-scale, placebo-controlled randomized trials.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">psychedelics, psilocybin, ayahuasca, LSD, psychological effects, depression, anxiety, meta-analysis</span></div></div><div id="S5" class="tsec sec"><h2 class="head no_bottom_margin" id="S5title">Introduction</h2><p id="P5" class="p p-first">Humans have intentionally consumed psychoactive substances for thousands of years (<a href="#R31" rid="R31" class=" bibr popnode">Guerra-Doce, 2015</a>). Psychedelic substances, in particular, figure prominently in indigenous medical and religious practices around the world (<a href="#R65" rid="R65" class=" bibr popnode">Samorini, 2019</a>; <a href="#R68" rid="R68" class=" bibr popnode">Schultes, 1969</a>). Scientific interest during the 1950s and 1960s in the therapeutic potential of both plant-based psychedelics (e.g., psilocybin) and synthetic psychedelics (e.g., lysergic acid diethylamide [LSD]) largely ceased following legislative changes during the 1970s and 1980s (<a href="#R6" rid="R6" class=" bibr popnode">Bonson, 2018</a>). Research has resumed in the past two decades. While early work in this contemporary period focused on pharmacokinetics (e.g., <a href="#R8" rid="R8" class=" bibr popnode">Callaway et al., 1999</a>) or the use of psychedelics as a model for psychiatric conditions (e.g., schizophrenia; <a href="#R79" rid="R79" class=" bibr popnode">Vollenweider et al., 1998</a>), a growing number of studies are again evaluating the therapeutic potential of psychedelics (<a href="#R59" rid="R59" class=" bibr popnode">Reiff et al., 2020</a>).</p><p id="P100">Classical psychedelics are a class of psychoactive substances that share both mode of action (agonism of the 5-HT<sub>2A</sub> receptor; <a href="#R9" rid="R9" class=" bibr popnode">Carhart-Harris, 2019</a>) and psychoactive effects (marked cognitive, affective, and perceptual changes). Members of this class that have received recent scientific attention include psilocybin, ayahuasca, and LSD (<a href="#R21" rid="R21" class=" bibr popnode">dos Santos et al., 2018</a>). Psilocybin (4-phosphoroyloxy-N,N-dimethyltryptamine) is a naturally occurring plant alkaloid used ritualistically for spiritual and healing purposes by indigenous cultures in Mexico and South America (<a href="#R32" rid="R32" class=" bibr popnode">Guzm&#x000e1;n, 2008</a>). Ayahuasca is a plant-based serotonergic psychedelic also used ritualistically by indigenous cultures in South America (<a href="#R47" rid="R47" class=" bibr popnode">McKenna, 2004</a>). The psychoactive effects of ayahuasca are due to N,N-dimethyltryptamine (DMT) coupled with reversible monoamine oxidase inhibitors (MAO-A; <a href="#R53" rid="R53" class=" bibr popnode">Ott, 1999</a>). LSD is a synthetic psychedelic first synthesized in 1943 by Albert <a href="#R36" rid="R36" class=" bibr popnode">Hofmann (1980)</a> that is both a serotonin and dopamine receptor agonist (<a href="#R24" rid="R24" class=" bibr popnode">Giacomelli, Palmery, Romanelli, Cheng, &#x00026; Silvestrini, 1998</a>; <a href="#R55" rid="R55" class=" bibr popnode">Preller et al., 2017</a>). Numerous studies in the 1960s investigated the therapeutic effects of LSD for the treatment of addiction (<a href="#R41" rid="R41" class=" bibr popnode">Krebs &#x00026; Johansen, 2012</a>) and other clinical applications (e.g., end-of-life distress; <a href="#R63" rid="R63" class=" bibr popnode">Ross, 2018</a>). Research halted as LSD became associated with the countercultural revolution of the late 1960s coupled with concerns regarding its safety (<a href="#R52" rid="R52" class=" bibr popnode">Nutt, King, &#x00026; Nichols, 2013</a>).</p><p id="P6">Studies have begun reexamining the therapeutic potential of classical psychedelics for clinical conditions including depression (<a href="#R10" rid="R10" class=" bibr popnode">Carhart-Harris et al., 2018a</a>; <a href="#R54" rid="R54" class=" bibr popnode">Palhano-Fontes et al., 2019</a>), anxiety (<a href="#R23" rid="R23" class=" bibr popnode">Gasser et al., 2014</a>; <a href="#R64" rid="R64" class=" bibr popnode">Ross et al., 2016</a>), and substance use (<a href="#R5" rid="R5" class=" bibr popnode">Bogenschutz et al., 2015</a>; <a href="#R38" rid="R38" class=" bibr popnode">Johnson, Garcia-Romeu, Cosimano, &#x00026; Griffiths, 2014</a>). Often psychedelics are paired with behavioral interventions intended to maximize benefits by enhancing the mental &#x0201c;set&#x0201d; and physical &#x0201c;setting&#x0201d; (<a href="#R14" rid="R14" class=" bibr popnode">Carhart-Harris et al., 2018b</a>). Other studies have examined effects in non-clinical samples on measures of well-being, personality, and associated constructs (e.g., mindfulness, spirituality; <a href="#R46" rid="R46" class=" bibr popnode">MacLean, Johnson, &#x00026; Griffiths, 2011</a>; <a href="#R69" rid="R69" class=" bibr popnode">Soler et al., 2018</a>).</p><p id="P7">Several systematic reviews have examined the safety and efficacy of psychedelics for both clinical and non-clinical populations. These narrative reviews consistently suggest psychedelics can be safely administered (i.e., adverse effects are minimal and transient) and may reduce depression and anxiety symptoms (<a href="#R50" rid="R50" class=" bibr popnode">Muttoni, Ardissino, &#x00026; John, 2019</a>), provide psychological benefits in the context of life-threatening disease (<a href="#R58" rid="R58" class=" bibr popnode">Reiche et al., 2018</a>), and induce mystical experiences associated with enduring changes in personality and attitudes (<a href="#R1" rid="R1" class=" bibr popnode">Aday, Mitzkovitz, Bloesch, Davoli, &#x00026; Davis, 2020</a>). Despite several well-conducted systematic reviews, only two quantitative reviews (i.e., meta-analyses) have characterized the efficacy of psychedelics. <a href="#R41" rid="R41" class=" bibr popnode">Krebs and Johansen (2012)</a> meta-analyzed six randomized controlled trials (RCTs) published between 1966 and 1970 testing LSD for alcoholism, finding LSD substantially reduced substance misuse (odds ratio=1.96). <a href="#R25" rid="R25" class=" bibr popnode">Goldberg et al. (2020)</a> found that psilocybin was associated with large reductions in depression and anxiety across four recent studies (Hedges&#x02019; <em>g</em>s=0.82 to 1.47).</p><p id="P8">The available reviews suggest psychedelics may have therapeutic potential. Yet, a clear quantitative depiction of the breadth of this literature is lacking. A comprehensive meta-analysis would be valuable for characterizing the magnitude and variability (i.e., heterogeneity) of the effect of psychedelics across psychological outcomes, including but not limited to psychiatric symptoms. Such a meta-analysis would be particularly valuable for clarifying effects that have been inconsistent in prior studies (e.g., effects on personality; <a href="#R46" rid="R46" class=" bibr popnode">MacLean et al., 2011</a>; <a href="#R2" rid="R2" class=" bibr popnode">Barrett et al., 2020</a>). The small sample size in many primary studies (e.g., mean <em>n</em>=29.25; <a href="#R25" rid="R25" class=" bibr popnode">Goldberg et al., 2020</a>) also recommends the use of meta-analysis which allows aggregation across studies. Lastly, meta-analysis offers the opportunity to examine whether various study-level features (e.g., psychedelic type, behavioral support) moderate effects.</p><p id="P9" class="p p-last">The current study sought to address this gap in the literature by quantitatively synthesizing psychological effects from experimental studies testing psilocybin, ayahuasca, or LSD. We focus on these three substances due to their shared mechanism of action (5-HT<sub>2A</sub> receptor agonism) and subjective effects. Other psychoactive compounds that produce partially overlapping effects through partially overlapping mechanisms were not considered (e.g., enactogens such as 3,4-Methylenedioxymethamphetamine [MDMA]; <a href="#R59" rid="R59" class=" bibr popnode">Reiff et al., 2020</a>). Given our interest in therapeutic applications, we focus on effects outside of the acute period of intoxication. To provide the most comprehensive depiction, we included studies with either clinical or non-clinical (i.e., healthy) samples. Likewise, we included both between-group (e.g., RCTs) and within-group (e.g., pre-post) designs. Four study-level characteristics (psychedelic type, clinical sample, presence of behavioral support, percentage female) were examined as moderators. We also assess adverse effects and risk of bias within and between studies.</p></div><div id="S6" class="tsec sec"><h2 class="head no_bottom_margin" id="S6title">Method</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Protocol and Registration</h3><p id="P10" class="p p-first-last">We followed the PRISMA guidelines (<a href="#R49" rid="R49" class=" bibr popnode">Moher et al., 2009</a>). This meta-analysis was pre-registered through the Open Science Framework (<a href="https://osf.io/79y5v/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://osf.io/79y5v/</a>). Upon reviewing the available studies, we made several deviations. First, we restricted our focus to post-acute effects given the acute hallucinogenic effects have been well characterized (e.g., <a href="#R75" rid="R75" class=" bibr popnode">Studerus, Kometer, Hasler, &#x00026; Vollenweider, 2011</a>) and are less relevant for therapeutic purposes. Second, there were insufficient studies to test moderation by specific clinical condition (e.g., depression vs. anxiety disorders). Instead, we report results restricted to clinical samples and to samples with depression. Third, no waitlist control conditions were available to compare with placebo-controlled studies. Fourth, we aggregated outcomes into conceptually coherent categories based on measures reported across studies. This led to the addition of some categories (e.g., adverse effects) and exclusion of some that were rarely reported (e.g., substance use).</p></div><div id="S8" class="sec"><h3 id="S8title">Eligibility Criteria</h3><p id="P11" class="p p-first-last">Eligible studies involved the administration of psilocybin, ayahuasca, or LSD within an experimental setting (i.e., not a naturalistic settings). Studies were required to report at least one psychological outcome. We maintained a broad definition of psychological to include psychiatric symptoms as well as non-clinical measures (e.g., well-being, spirituality). However, measures primarily focused on the acute psychedelic experience itself (e.g., altered states of consciousness; <a href="#R74" rid="R74" class=" bibr popnode">Studerus, Gamma, &#x00026; Vollenweider, 2010</a>) were excluded. Outcomes were assessed outside of the period of acute intoxication, which we operationalized as &#x02265; 24 hours post-administration of the psychedelic, consistent with prior studies (e.g., <a href="#R67" rid="R67" class=" bibr popnode">Schmid et al., 2015</a>). Studies with and without behavioral support were eligible. Both single group (e.g., within-group pre-post) or between-group designs (e.g., placebo-controlled RCT) were eligible. Both clinical and non-clinical samples were eligible. No restriction was placed on language or publication status. Studies were excluded if they were missing data necessary for computing effect sizes. Studies that only reported post-treatment data without a baseline measurement or a relevant control group (e.g., persisting effects at post-treatment for a single-group design; <a href="#R51" rid="R51" class=" bibr popnode">Nicholas et al., 2018</a>) were excluded. Principal investigators of completed clinical trials were contacted regarding available results.</p></div><div id="S9" class="sec"><h3 id="S9title">Information Sources</h3><p id="P12" class="p p-first-last">We searched six databases including PubMed, CINAHL, PsycINFO, Web of Science, Scopus, and Cochrane. We restricted our search to studies from the contemporary period of psychedelic research (1990 or later). This window captured the period when research on classical psychedelics resumed (e.g., <a href="#R72" rid="R72" class=" bibr popnode">Strassman et al. 1994</a>) but excluded early research (1950s to 1960s) conducted under sufficiently different methodological standards such that safety and efficacy data may not be interpretable (<a href="#R6" rid="R6" class=" bibr popnode">Bonson, 2018</a>). The search was conducted between October 23<sup>rd</sup> and 31<sup>st</sup>, 2019. In addition, we hand searched recent systematic reviews (<a href="#R1" rid="R1" class=" bibr popnode">Aday et al., 2020</a>; <a href="#R7" rid="R7" class=" bibr popnode">Bouso et al., 2018</a>; <a href="#R21" rid="R21" class=" bibr popnode">dos Santos et al., 2018</a>; <a href="#R40" rid="R40" class=" bibr popnode">Jungaberle et al., 2018</a>; <a href="#R50" rid="R50" class=" bibr popnode">Muttoni et al., 2019</a>; <a href="#R58" rid="R58" class=" bibr popnode">Reiche et al., 2018</a>; <a href="#R59" rid="R59" class=" bibr popnode">Reiff et al., 2020</a>; <a href="#R66" rid="R66" class=" bibr popnode">Schenberg et al., 2018</a>).</p></div><div id="S10" class="sec"><h3 id="S10title">Search</h3><p id="P13" class="p p-first-last">We paired search terms associated with the three psychedelics of interest (e.g., &#x0201c;psilocybin,&#x0201d; &#x0201c;ayahuasca,&#x0201d; &#x0201c;LSD,&#x0201d; &#x0201c;psychedelic*&#x0201d;) with terms related to both clinical (e.g., &#x0201c;mental disorders,&#x0201d; &#x0201c;depression,&#x0201d; &#x0201c;anx*&#x0201d;) and non-clinical populations (e.g., &#x0201c;well-being,&#x0201d; &#x0201c;quality of life,&#x0201d; &#x0201c;healthy&#x0201d;). The full search terms for all six databases are shown in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 1</a>.</p></div><div id="S11" class="sec"><h3 id="S11title">Study Selection</h3><p id="P14" class="p p-first-last">Two authors independently reviewed each title and/or abstract of potential studies for inclusion. Full texts were reviewed for studies that passed initial screening. Disagreements were discussed with the first author until consensus was reached.</p></div><div id="S12" class="sec"><h3 id="S12title">Data Collection Process</h3><p id="P15" class="p p-first-last">Standardized spreadsheets were developed for study- and effect size-level coding. The first and second authors independently extracted data. Inter-rater reliabilities were good to excellent (i.e., Ks and ICCs&#x02265;0.74; <a href="#R15" rid="R15" class=" bibr popnode">Cicchetti, 1994</a>).</p></div><div id="S13" class="sec"><h3 id="S13title">Data Items</h3><p id="P16" class="p p-first-last">In addition to data necessary for computing effect sizes (e.g., sample sizes, means, standard deviations), we extracted: (1) study design, (2) psychedelic type and dose and control condition, (3) inclusion criteria, (4) adverse events, (5) post-treatment and follow-up timing, (6) behavioral support, (7) sample age and sex composition, (8) country, (9) and retention. We also extracted data necessary for coding risk of bias with the Cochrane tool (<a href="#R34" rid="R34" class=" bibr popnode">Higgins &#x00026; Green, 2008</a>). Outcomes were grouped into categories that were intended to be both parsimonious and conceptually coherent. This yielded 14 categories: adverse effects (i.e., symptoms potentially associated with negative drug effects such as psychotic symptoms or mania), targeted symptoms of psychiatric disorders (e.g., alcohol use for samples with alcohol use disorder), depression for samples with depression (as this was the most common psychiatric disorder studied), negative affect-related outcomes (e.g., negative mood, anxiety), positive affect-related outcomes (e.g., joy), social outcomes (e.g., altruism), behavior (e.g., observer-rated behavior change), existential and spiritual outcomes (e.g., death transcendence, lifetime mystical experience), mindfulness, and the big five personality traits (i.e., openness, neuroticism, extraversion, agreeableness, conscientiousness).</p></div><div id="S14" class="sec"><h3 id="S14title">Risk of Bias in Individual Studies</h3><p id="P17" class="p p-first-last">Risk of bias was evaluated using the Cochrane tool (<a href="#R34" rid="R34" class=" bibr popnode">Higgins &#x00026; Green, 2008</a>). Bias was assessed across five domains: selection bias (random sequence generation, allocation concealment), performance bias (blinding of participants and personnel), detection bias (blinding of outcome assessors), attrition bias (incomplete outcome data), and reporting bias (selective reporting). For each study, an evaluation of low, high, or unclear risk of bias was made.</p></div><div id="S15" class="sec"><h3 id="S15title">Summary Measures</h3><p id="P18" class="p p-first">Effect sizes in standardized units were calculated using standard meta-analytic methods (<a href="#R18" rid="R18" class=" bibr popnode">Cooper, Hedges, &#x00026; Valentine, 2009</a>). Specifically, a within-group pre-post and pre-follow-up <a href="#R17" rid="R17" class=" bibr popnode">Cohen&#x02019;s (1988)</a>
<em>d</em> was computed for all studies providing eligible data. The pre-post effect used baseline and the first available data collected post-treatment. To provide the most conservative estimate of effects at follow-up, pre-follow-up effects used data from the last available follow-up. For within-group effects, we assumed a correlation of <em>r</em><sub>xx</sub>=.50 between timepoints (<a href="#R37" rid="R37" class=" bibr popnode">Hoyt &#x00026; Del Re, 2018</a>). For controlled studies, a between-group effect size was also computed. When pre-post data were available for both the treatment and control conditions, within-group effects were computed for each group separately. Then, the between-group effect was computed as the difference between within-group effects (i.e., <a href="#R3" rid="R3" class=" bibr popnode">Becker&#x02019;s [1988</a>] del). This effect size has the advantage of accounting for baseline data. When within-group effects were not available (e.g., outcomes like persisting effects assessed only at post-treatment; <a href="#R30" rid="R30" class=" bibr popnode">Griffiths et al., 2006</a>), a between-group Cohen&#x02019;s <em>d</em> was computed. To provide the most conservative estimate of controlled effects, we used data from the last available follow-up timepoint. For randomized controlled cross-over designs in which both groups ultimately received the active treatment (e.g., <a href="#R64" rid="R64" class=" bibr popnode">Ross et al., 2016</a>), we used data from the last timepoint prior to cross-over. For within-person RCTs that included multiple dosages (e.g., <a href="#R4" rid="R4" class=" bibr popnode">Bershad et al., 2019</a>), we compared the placebo condition with the highest dose condition.</p><p id="P19" class="p p-last">In order to decrease the influence of selective reporting bias (<a href="#R34" rid="R34" class=" bibr popnode">Higgins &#x00026; Green, 2008</a>), we attempted to represent all outcome measures that were assessed. Authors were contacted regarding measures described in the Method section but not included in the Results section. When data remained missing at the time of analysis, we represented effects described in the text as non-significant as <em>d</em>=0.00. Authors were also contacted when adverse effects were not mentioned in the published report.</p></div><div id="S16" class="sec"><h3 id="S16title">Synthesis of Results</h3><p id="P20" class="p p-first-last">Using standard meta-analytic methods (<a href="#R18" rid="R18" class=" bibr popnode">Cooper et al., 2009</a>), effects were aggregated first within measure (e.g., subscales of the Depression Anxiety and Stress Scale [<a href="#R42" rid="R42" class=" bibr popnode">Lovibond &#x00026; Lovibond, 1995</a>]) and then within study using the &#x02018;MAd&#x02019; package (<a href="#R20" rid="R20" class=" bibr popnode">Del Re &#x00026; Hoyt, 2014</a>) in R (<a href="#R57" rid="R57" class=" bibr popnode">R Core Team, 2018</a>). As noted previously, separate analyses examined effects for specific outcome domains. Meta-analytic effect sizes with an associated 95% confidence interval (CI) was computed when at least two studies were available for a specific estimate (<a href="#R76" rid="R76" class=" bibr popnode">Valentine, Pigott, &#x00026; Rothstein, 2010</a>). Summary effects were converted from Cohen&#x02019;s <em>d</em> to Hedges&#x02019; <em>g</em> in order to account for small sample bias (<a href="#R18" rid="R18" class=" bibr popnode">Cooper et al., 2009</a>). As appropriate, the sign for each effect was reversed so that a positive <em>g</em> always indicated improvement (e.g., decreased depression, increased well-being). Magnitude was interpreted based on <a href="#R17" rid="R17" class=" bibr popnode">Cohen&#x02019;s (1988)</a> guidelines. Separate aggregate effect size estimates were computed for within-group effects at post-treatment and follow-up and for between-group effects at last available post-treatment assessment. Heterogeneity was characterized using I<sup>2</sup> (i.e., proportion of heterogeneity that is between-study heterogeneity) and interpreted based on <a href="#R35" rid="R35" class=" bibr popnode">Higgins et al.&#x02019;s (2003)</a> guidelines. Random effects models with weighting based on the inverse of the variance of each study&#x02019;s effect size was implemented through the &#x02018;metafor&#x02019; package (<a href="#R77" rid="R77" class=" bibr popnode">Viechtbauer, 2010</a>).</p></div><div id="S17" class="sec"><h3 id="S17title">Risk of Bias across Studies</h3><p id="P21" class="p p-first-last">We assessed publication bias using trim-and-fill analyses in the &#x02018;metafor&#x02019; package. When funnel plot asymmetry was detected, an adjusted effect size was computed with studies imputed to account for asymmetry. Due to the small number of studies in some analyses, which limits statistical power, these tests were considered exploratory. In addition, we calculated the fail-safe Ns to represent the number of non-significant results that would need to exist to nullify an observed effect (<a href="#R62" rid="R62" class=" bibr popnode">Rosenthal, 1979</a>).</p></div><div id="S18" class="sec sec-last"><h3 id="S18title">Additional Analyses</h3><p id="P22" class="p p-first-last">We tested four study-level characteristics as moderators. These included the psychedelic type (coded as 1=psilocybin, 0=LSD or ayahuasca), whether the sample was clinical (i.e., required elevated symptoms of a medical/psychiatric diagnosis for inclusion) or non-clinical (i.e., healthy controls), whether behavioral support was provided (e.g., pre-treatment preparation), and percentage female. Psilocybin was compared with LSD or ayahuasca as the majority of studies investigated psilocybin (<em>k</em>=14). Insufficient studies were available to adequately compare psilocybin with LSD (<em>k</em>=4) and ayahuasca (<em>k</em>=6) separately, or LSD and ayahuasca with each other. We also conducted sensitivity analyses with outliers excluded. There are several methods for identifying outliers in meta-analysis (<a href="#R78" rid="R78" class=" bibr popnode">Viechtbauer &#x00026; Cheung, 2010</a>). We used the &#x02018;find.outliers&#x02019; function provided by <a href="#R33" rid="R33" class=" bibr popnode">Harrer, Cuijpers, Furukawa, and Ebert (2019)</a> which defines an outlier as a study whose confidence interval does not overlap the omnibus effect confidence interval.</p></div></div><div id="S19" class="tsec sec"><h2 class="head no_bottom_margin" id="S19title">Results</h2><div id="S20" class="sec sec-first"><h3 id="S20title">Study Selection</h3><p id="P23" class="p p-first-last">Our search produced a total of 14,591 citations. After removing 4,540 duplicates, 10,051 unique titles and/or abstracts were reviewed. After applying our exclusion criteria (<a href="/pmc/articles/PMC7855004/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>), we retained 34 studies representing 24 unique samples and 549 participants (see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 2</a> for a list of the 34 studies). Studies were published between 2006 and 2020.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC7855004/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140131407629760"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1635180-f0001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1635180-f0001.jpg" src="/pmc/articles/PMC7855004/bin/nihms-1635180-f0001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140131407629760"><a target="object" rel="noopener" href="/pmc/articles/PMC7855004/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC7855004/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1.</a></div><!--caption a7--><div class="caption"><p id="P48">PRISMA flow diagram</p></div></div></div></div><div id="S21" class="sec"><h3 id="S21title">Study Characteristics</h3><p id="P24" class="p p-first">Study-level characteristics are reported in <a href="/pmc/articles/PMC7855004/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. Half of the studies used single-group pre-post designs (50.0%) with the remainder being within-group RCTs (i.e., participants received all conditions in random order; 16.7%), or between-group RCTs (33.3%). The majority of studies tested psilocybin (58.3%) with 25.0% testing ayahuasca and 16.7% testing LSD. Dosages of each psychedelic and placebo control conditions are listed in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 3</a>. Post-test assessment occurred on average at 5.54 weeks post-treatment (<em>SD</em>=6.48, range=0 to 26.00). Most studies (54.2%) included a follow-up assessment. For studies with a follow-up assessment, last follow-up occurred on average 53.34 weeks (<em>SD</em>=64.25) post-treatment (range=3 to 234.90). Retention at post-treatment was 94.5% (<em>SD</em>=10.0) and 85.6% (<em>SD</em>=16.9) at follow-up.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="P51">Study characteristics</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Study</th><th align="left" valign="top" rowspan="1" colspan="1">Design</th><th align="left" valign="top" rowspan="1" colspan="1">Sample</th><th align="left" valign="top" rowspan="1" colspan="1">Psychedelic</th><th align="left" valign="top" rowspan="1" colspan="1">Behav</th><th align="left" valign="top" rowspan="1" colspan="1">N<sub>tx</sub></th><th align="left" valign="top" rowspan="1" colspan="1">N<sub>cont</sub></th><th align="left" valign="top" rowspan="1" colspan="1">Wk<sub>post</sub></th><th align="left" valign="top" rowspan="1" colspan="1">Wk<sub>FU</sub></th><th align="left" valign="top" rowspan="1" colspan="1">Age</th><th align="left" valign="top" rowspan="1" colspan="1">% Fem</th><th align="left" valign="top" rowspan="1" colspan="1">% White</th><th align="left" valign="top" rowspan="1" colspan="1">Ret<sub>post</sub></th><th align="left" valign="top" rowspan="1" colspan="1">Ret<sub>FU</sub></th><th align="left" valign="top" rowspan="1" colspan="1">Country</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Anderson-2019</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">AIDS survivors</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R2" rid="R2" class=" bibr popnode">Barrett-2020</a></td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">32.1</td><td align="left" valign="top" rowspan="1" colspan="1">58</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R4" rid="R4" class=" bibr popnode">Bershad-2019</a></td><td align="left" valign="top" rowspan="1" colspan="1">Within-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">LSD</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">60</td><td align="left" valign="top" rowspan="1" colspan="1">45</td><td align="left" valign="top" rowspan="1" colspan="1">55</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R5" rid="R5" class=" bibr popnode">Bogenschutz-2015</a></td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">alcohol dependence</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="left" valign="top" rowspan="1" colspan="1">40.1</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R13" rid="R13" class=" bibr popnode">Carhart-Harris-2012</a></td><td align="left" valign="top" rowspan="1" colspan="1">Within-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">30.5</td><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">England</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R12" rid="R12" class=" bibr popnode">Carhart-Harris-2016b</a></td><td align="left" valign="top" rowspan="1" colspan="1">Within-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">LSD</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">30.9</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">England</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R10" rid="R10" class=" bibr popnode">Carhart-Harris-2018a</a></td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">depression</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">44.1</td><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">75</td><td align="left" valign="top" rowspan="1" colspan="1">95</td><td align="left" valign="top" rowspan="1" colspan="1">95</td><td align="left" valign="top" rowspan="1" colspan="1">England</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R23" rid="R23" class=" bibr popnode">Gasser-2014</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">anxiety + life-threat disease</td><td align="left" valign="top" rowspan="1" colspan="1">LSD</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">52</td><td align="left" valign="top" rowspan="1" colspan="1">51.7</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">75</td><td align="left" valign="top" rowspan="1" colspan="1">Switzerland</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R30" rid="R30" class=" bibr popnode">Griffiths-2006</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">religious/spiritual healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">56</td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">61</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R28" rid="R28" class=" bibr popnode">Griffiths-2011</a></td><td align="left" valign="top" rowspan="1" colspan="1">Within-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">56</td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">56</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R26" rid="R26" class=" bibr popnode">Griffiths-2016</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">cancer + depression/anxiety</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">29</td><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">56.3</td><td align="left" valign="top" rowspan="1" colspan="1">49</td><td align="left" valign="top" rowspan="1" colspan="1">94</td><td align="left" valign="top" rowspan="1" colspan="1">91</td><td align="left" valign="top" rowspan="1" colspan="1">82</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R27" rid="R27" class=" bibr popnode">Griffiths-2018</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">57</td><td align="left" valign="top" rowspan="1" colspan="1">28</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="left" valign="top" rowspan="1" colspan="1">60</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">88</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Grob-2011</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">cancer + anxiety</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">67</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R38" rid="R38" class=" bibr popnode">Johnson-2014</a></td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">smokers</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">130.5</td><td align="left" valign="top" rowspan="1" colspan="1">51</td><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="left" valign="top" rowspan="1" colspan="1">93</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">80</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Madsen-2020</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">28.4</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Denmark</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Osorio-2015</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">depression</td><td align="left" valign="top" rowspan="1" colspan="1">ayahuasca</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">44.2</td><td align="left" valign="top" rowspan="1" colspan="1">67</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R54" rid="R54" class=" bibr popnode">Palhano-Fontes-2019</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">depression</td><td align="left" valign="top" rowspan="1" colspan="1">ayahuasca</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">42.0</td><td align="left" valign="top" rowspan="1" colspan="1">72</td><td align="left" valign="top" rowspan="1" colspan="1">59</td><td align="left" valign="top" rowspan="1" colspan="1">83</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R64" rid="R64" class=" bibr popnode">Ross-2016</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">cancer + anxiety</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">234.9</td><td align="left" valign="top" rowspan="1" colspan="1">56.3</td><td align="left" valign="top" rowspan="1" colspan="1">62</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">45</td><td align="left" valign="top" rowspan="1" colspan="1">US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sampedro-2017</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">ayahuasca</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">38.9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">88</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Spain</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sanches-2016</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">depression</td><td align="left" valign="top" rowspan="1" colspan="1">ayahuasca</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">42.7</td><td align="left" valign="top" rowspan="1" colspan="1">82</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Schmid-2018</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">LSD</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">52</td><td align="left" valign="top" rowspan="1" colspan="1">28.6</td><td align="left" valign="top" rowspan="1" colspan="1">50</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">94</td><td align="left" valign="top" rowspan="1" colspan="1">Switzerland</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R71" rid="R71" class=" bibr popnode">Smigielski-2019b</a></td><td align="left" valign="top" rowspan="1" colspan="1">Between-group RCT</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">psilocybin</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">51.7</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">95</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Switzerland</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Soler-2016</td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">healthy</td><td align="left" valign="top" rowspan="1" colspan="1">ayahuasca</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">43.6</td><td align="left" valign="top" rowspan="1" colspan="1">56</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Spain</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R69" rid="R69" class=" bibr popnode">Soler-2018</a></td><td align="left" valign="top" rowspan="1" colspan="1">Single group pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">general population</td><td align="left" valign="top" rowspan="1" colspan="1">ayahuasca</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">50</td><td align="left" valign="top" rowspan="1" colspan="1">70</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">Spain</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140131360028896"><a target="object" rel="noopener" href="/pmc/articles/PMC7855004/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="P52" class="p p-first-last">Note: Behav = inclusion of behavioral support (e.g., preparation prior to psychedelic administration); N = sample size; tx = treatment; cont = control; Wk<sub>post</sub> = week of post-treatment assessment; Wk<sub>FU</sub> = week of follow-up assessment; Fem = female; Ret<sub>post</sub> = % of sample retained at post-treatment assessment; Ret<sub>FU</sub> = % of sample retained at follow-up assessment; NA = not available; life-threat disease = life-threatening disease.</p></div></div></div><p id="P25" class="p p-last">Sample sizes were generally small, on average 22.88 participants (<em>SD</em>=17.42, range=6 to 85). Mean age was 42.13 years old and the samples were 51.5% female. Among the studies that reported race/ethnicity (37.5% of studies), 74.6% were non-Hispanic white or Caucasian. Studies were conducted in the US (45.8%), Europe (41.7%), and Brazil (12.5%). Approximately half of the studies (45.8%) included participants with clinical conditions. The most common clinical condition was depression (<em>k</em>=4). Other clinical conditions included cancer/life-threatening diseases with comorbid anxiety and/or depression (<em>k</em>=3), alcohol dependence (<em>k</em>=1), smoking (<em>k</em>=1), and AIDS (<em>k</em>=1).</p></div><div id="S22" class="sec"><h3 id="S22title">Risk of Bias within Studies</h3><p id="P26" class="p p-first-last">Risk of bias varied, often based on whether a single-group design was used (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 4</a>). Single-group designs lacked randomization and other features (e.g., blinding) that increase confidence that effects are associated with the active treatment. Risk of bias also varied across domains (<a href="/pmc/articles/PMC7855004/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). Blinding of participants and personnel and blinding of outcome assessment were the domains most at risk for bias. Selective reporting bias was commonly rated as unclear due to difficulty determining whether the reported outcomes were planned.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC7855004/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140131360034560"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1635180-f0002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1635180-f0002.jpg" src="/pmc/articles/PMC7855004/bin/nihms-1635180-f0002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140131360034560"><a target="object" rel="noopener" href="/pmc/articles/PMC7855004/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC7855004/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2.</a></div><!--caption a7--><div class="caption"><p id="P49">Cochrane risk of bias assessment. Random sequence = random sequence generation; Allocat Concealment = allocation concealment; Blinding Person/Partic = blinding of personnel and participants; Blind Outcome = blinding of outcome assessment; Attrition bias = incomplete outcome data.</p></div></div></div></div><div id="S23" class="sec"><h3 id="S23title">Results of Individual Studies</h3><p id="P27" class="p p-first-last">Effect size-level data are reported by study, domain, timepoint, and design in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 5</a>. The outcome measures included across studies are listed in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 6</a> along with their corresponding domain.</p></div><div id="S24" class="sec"><h3 id="S24title">Synthesis of Results</h3><div id="S25" class="sec sec-first"><p></p><h4 id="S25title" class="inline">Adverse effects. </h4><p id="P28" class="p p-first">Adverse effects were available for 79.2% of studies (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 3</a>). Among those reporting adverse effects, none reported serious adverse effects (e.g., death, hospitalization). Commonly reported transient adverse effects included headache, anxiety, nausea, and increased blood pressure.</p><p id="P29" class="p p-last">Several studies (29.2%) also included measures of longer-term adverse effects that could be used to quantify the magnitude of these effects (e.g., psychotic symptoms, mania, persisting negative effects; see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 6</a>). There was no evidence that psychedelics increased risk for adverse effects. In fact, within-group effects suggested decreased adverse effects at post-treatment and follow-up (<em>g</em>s=0.40 and 0.50, respectively; <a href="/pmc/articles/PMC7855004/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). As noted above, a positive effect size indicates a reduction in adverse effects. Heterogeneity was low for within-group pre-post comparisons but moderate to high for within-group pre-follow-up and between-group comparisons.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="P53">Meta-analytic estimates of effects of classical psychedelics across outcome domains</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Domain</th><th align="left" valign="top" rowspan="1" colspan="1">Comparison</th><th align="left" valign="top" rowspan="1" colspan="1">Timepoint</th><th align="left" valign="top" rowspan="1" colspan="1">N</th><th align="left" valign="top" rowspan="1" colspan="1">K</th><th align="left" valign="top" rowspan="1" colspan="1">ES [95% CI]</th><th align="left" valign="top" rowspan="1" colspan="1">I<sup>2</sup> [95% CI]</th><th align="left" valign="top" rowspan="1" colspan="1">k<sub>imp</sub></th><th align="left" valign="bottom" rowspan="1" colspan="1">ES<sub>adj</sub></th><th align="left" valign="top" rowspan="1" colspan="1">FSN</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Targeted sx</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">126</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">1.70 [1.16, 2.23]</td><td align="left" valign="top" rowspan="1" colspan="1">84.19 [65.56, 95.68]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">1.70 [1.16, 2.23]</td><td align="left" valign="top" rowspan="1" colspan="1">803</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Targeted sx</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">142</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">1.37 [0.95, 1.80]</td><td align="left" valign="top" rowspan="1" colspan="1">79.52 [53.83, 94.48]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">1.37 [0.95, 1.80]</td><td align="left" valign="top" rowspan="1" colspan="1">657</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Targeted sx</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">67</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 [0.74, 1.43]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 93.15]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 [0.74, 1.43]</td><td align="left" valign="top" rowspan="1" colspan="1">69</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Depression</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">49</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">2.06 [1.41, 2.71]</td><td align="left" valign="top" rowspan="1" colspan="1">62.58 [0.00, 97.86]</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">1.83 [1.10, 2.55]</td><td align="left" valign="top" rowspan="1" colspan="1">152</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Depression</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">1.57 [0.90, 2.24]</td><td align="left" valign="top" rowspan="1" colspan="1">63.92 [0.00, 99.09]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">1.57 [0.90, 2.24]</td><td align="left" valign="top" rowspan="1" colspan="1">67</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Depression</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neg affect</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">182</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">1.05 [0.60, 1.49]</td><td align="left" valign="top" rowspan="1" colspan="1">89.09 [79.11, 96.21]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">1.05 [0.60, 1.49]</td><td align="left" valign="top" rowspan="1" colspan="1">818</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neg affect</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">157</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">0.99 [0.54, 1.43]</td><td align="left" valign="top" rowspan="1" colspan="1">87.17 [72.29, 96.17]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.99 [0.54, 1.43]</td><td align="left" valign="top" rowspan="1" colspan="1">509</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neg affect</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">82</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">0.87 [0.46, 1.28]</td><td align="left" valign="top" rowspan="1" colspan="1">43.12 [0.00, 91.83]</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.67 [0.27, 1.08]</td><td align="left" valign="top" rowspan="1" colspan="1">66</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pos affect</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">139</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">0.44 [0.15, 0.73]</td><td align="left" valign="top" rowspan="1" colspan="1">70.83 [24.71, 94.67]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.44 [0.15, 0.73]</td><td align="left" valign="top" rowspan="1" colspan="1">71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pos affect</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">115</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.47 [0.13, 0.82]</td><td align="left" valign="top" rowspan="1" colspan="1">73.08 [26.51, 96.83]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.47 [0.13, 0.82]</td><td align="left" valign="top" rowspan="1" colspan="1">47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pos affect</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">163</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">0.89 [0.52, 1.25]</td><td align="left" valign="top" rowspan="1" colspan="1">71.45 [30.78, 93.59]</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">0.76 [0.33, 1.19]</td><td align="left" valign="top" rowspan="1" colspan="1">214</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adverse</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.40 [0.08, 0.71]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 99.89]</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">2<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adverse</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.50 [0.05, 0.95]</td><td align="left" valign="top" rowspan="1" colspan="1">42.78 [0.00, 99.94]</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">5<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adverse</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">96</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">0.46 [&#x02212;0.42, 1.33]</td><td align="left" valign="top" rowspan="1" colspan="1">92.55 [74.26, 99.52]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.46 [&#x02212;0.42, 1.33]</td><td align="left" valign="top" rowspan="1" colspan="1">9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Social</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">0.81 [0.36, 1.25]</td><td align="left" valign="top" rowspan="1" colspan="1">49.16 [0.00, 98.69]</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.43 [&#x02212;0.10, 0.97]</td><td align="left" valign="top" rowspan="1" colspan="1">25<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Social</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.53 [0.16, 0.90]</td><td align="left" valign="top" rowspan="1" colspan="1">24.88 [0.00, 97.64]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.53 [0.16, 0.90]</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Social</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">95</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">1.13 [0.76, 1.51]</td><td align="left" valign="top" rowspan="1" colspan="1">35.87 [0.00, 96.61]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">1.13 [0.76, 1.51]</td><td align="left" valign="top" rowspan="1" colspan="1">84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Behavior</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">87</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">1.47 [0.90, 2.04]</td><td align="left" valign="top" rowspan="1" colspan="1">33.57 [0.00, 99.89]</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">28</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Behavior</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Behavior</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">76</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">1.16 [0.78, 1.53]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 98.23]</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">24<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exist/spirit</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">159</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.56 [0.35, 0.76]</td><td align="left" valign="top" rowspan="1" colspan="1">50.73 [0.00, 88.07]</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.48 [0.28, 0.68]</td><td align="left" valign="top" rowspan="1" colspan="1">170</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exist/spirit</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">145</td><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">0.52 [0.27, 0.76]</td><td align="left" valign="top" rowspan="1" colspan="1">62.51 [13.36, 89.69]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.52 [0.27, 0.76]</td><td align="left" valign="top" rowspan="1" colspan="1">111</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exist/spirit</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">120</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.84 [0.53, 1.16]</td><td align="left" valign="top" rowspan="1" colspan="1">50.90 [0.00, 94.23]</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.64 [0.28, 1.00]</td><td align="left" valign="top" rowspan="1" colspan="1">103</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Openness</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">124</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.21 [0.04, 0.38]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 37.54]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.21 [0.04, 0.38]</td><td align="left" valign="top" rowspan="1" colspan="1">5<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Openness</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="bottom" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.20 [0.00, 0.40]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 77.94]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.20 [0.00, 0.40]</td><td align="left" valign="top" rowspan="1" colspan="1">2<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Openness</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">85</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.07 [&#x02212;0.22, 0.36]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 78.27]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.07 [&#x02212;0.22, 0.36]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neuroticism</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">124</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.06 [&#x02212;0.11, 0.23]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 88.92]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.06 [&#x02212;0.11, 0.23]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neuroticism</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.16 [&#x02212;0.05, 0.36]</td><td align="left" valign="top" rowspan="1" colspan="1">4.88 [0.00, 87.32]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.16 [&#x02212;0.05, 0.36]</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neuroticism</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">85</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [&#x02212;0.29, 0.29]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 0.00]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [&#x02212;0.29, 0.29]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extraversion</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">124</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.04 [&#x02212;0.13, 0.21]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 0.00]</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.01 [&#x02212;0.13, 0.15]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extraversion</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.18 [&#x02212;0.09, 0.44]</td><td align="left" valign="top" rowspan="1" colspan="1">41.19 [0.00, 93.22]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.18 [&#x02212;0.09, 0.44]</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extraversion</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">85</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [&#x02212;0.29, 0.29]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 0.00]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [&#x02212;0.29, 0.29]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Agreeable</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">124</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.05 [&#x02212;0.12, 0.23]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 53.53]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.05 [&#x02212;0.12, 0.23]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Agreeable</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.02 [&#x02212;0.21, 0.18]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 59.10]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.02 [&#x02212;0.21, 0.18]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Agreeable</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">85</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.09 [&#x02212;0.20, 0.38]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 87.19]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.09 [&#x02212;0.20, 0.38]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Conscientious</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">124</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.02 [&#x02212;0.15, 0.19]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 84.35]</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.01 [&#x02212;0.17, 0.15]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Conscientious</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">92</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.17 [&#x02212;0.03, 0.36]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 85.92]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.17 [&#x02212;0.03, 0.36]</td><td align="left" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Conscientious</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">85</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [&#x02212;0.29, 0.29]</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [0.00, 0.00]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 [&#x02212;0.29, 0.29]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mindfulness</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">81</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">0.45 [0.14, 0.77]</td><td align="left" valign="top" rowspan="1" colspan="1">60.84 [0.00, 95.86]</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">0.45 [0.14, 0.77]</td><td align="left" valign="top" rowspan="1" colspan="1">33<sup>a</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mindfulness</td><td align="left" valign="top" rowspan="1" colspan="1">Within-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-FU</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mindfulness</td><td align="left" valign="top" rowspan="1" colspan="1">Between-group</td><td align="left" valign="top" rowspan="1" colspan="1">pre-post</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140131404039488"><a target="object" rel="noopener" href="/pmc/articles/PMC7855004/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN2"><p id="P54" class="p p-first-last">Note: N = sample size; K = number of studies; CI = confidence interval; k<sub>imp</sub> = number of studies imputed for trim-and-fill adjustment; ES<sub>adj</sub> = trim-and-fill adjusted effect size; FSN = fail-safe N; Targeted sx = targeted symptoms within psychiatric samples; Depression = depression outcomes restricted to samples with depression; Neg = negative; Pos = positive; Exist/spirit = Existential / spiritual; ES = effect size in Hedges&#x02019; g units; FU = follow-up; NA = not available. Estimates based on k = 1 not included.</p></div><div id="TFN3"><sup>a =</sup>statistically significant result not robust to publication bias based on <a href="#R61" rid="R61" class=" bibr popnode">Rosenberg&#x02019;s (2005)</a> guidelines (i.e., fail-safe N &#x0003e; 5n + 10, where <em>n</em> = number of published studies).</div></div></div></div><div id="S26" class="sec"><p></p><h4 id="S26title" class="inline">Within-group effects. </h4><p id="P30" class="p p-first-last">Psychedelics showed statistically significant within-group improvements across several outcome domains at both post-treatment and follow-up (<a href="/pmc/articles/PMC7855004/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>, <a href="/pmc/articles/PMC7855004/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>). Domains showing beneficial effects included targeted symptoms within psychiatric samples, depression within samples with depression, negative affect, positive affect, social outcomes, and existential/spiritual outcomes. Associated effect sizes ranged from <em>g</em>s=0.44 (positive affect) to 2.06 (depression) and were fairly similar in magnitude at post-treatment and follow-up. Psychedelics showed improvements in behavior and mindfulness at post-treatment, although estimates were not available at follow-up. Psychedelics were not associated with changes in big five personality dimensions, with the exception of openness which showed a small increase. Heterogeneity was generally high (I<sup>2</sup>&#x0003e;50%).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC7855004/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140131360031472"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1635180-f0003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1635180-f0003.jpg" src="/pmc/articles/PMC7855004/bin/nihms-1635180-f0003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140131360031472"><a target="object" rel="noopener" href="/pmc/articles/PMC7855004/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC7855004/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3.</a></div><!--caption a7--><div class="caption"><p id="P50">Forest plots displaying effects of classical psychedelics across psychological outcome domains. Each point represents an effect size estimates (Hedges&#x02019; g units) and a corresponding 95% confidence interval. Targeted sx = targeted symptoms within psychiatric samples; Depression = depression outcomes restricted to samples with depression; Neg = negative; Pos = positive; Exist/spirit = Existential / spiritual; ES = effect size in Hedges&#x02019; g units; FU = follow-up; NA = not available.</p></div></div></div></div><div id="S27" class="sec sec-last"><p></p><h4 id="S27title" class="inline">Between-group effects. </h4><p id="P31" class="p p-first-last">Moderate to large and statistically significant between-group effects favored psychedelics relative to placebo controls across several outcome domains at longest follow-up. These included targeted symptoms within psychiatric samples, negative affect, positive affect, social outcomes, behavior, and existential/spiritual outcomes. Effect sizes ranged from <em>g</em>s=0.84 to 1.16. There was no evidence of between-group effects on personality. Heterogeneity was generally high (I<sup>2</sup>&#x0003e;50%).</p></div></div><div id="S28" class="sec"><h3 id="S28title">Risk of Bias across Studies</h3><p id="P32" class="p p-first-last">There was evidence of funnel plot asymmetry (i.e., publication bias) in eight models (<a href="/pmc/articles/PMC7855004/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Statistical significance was not impacted by this adjustment, with one exception (within-group pre-post effect on social outcomes which became non-significant, <em>g</em>=0.43 [&#x02212;0.10, 0.97]). Fail-safe Ns ranged from 0 to 803. Based on <a href="#R61" rid="R61" class=" bibr popnode">Rosenberg&#x02019;s (2005)</a> guidelines (i.e., fail-safe N&#x0003e;5n + 10, where <em>n</em>=number of published studies), within-group effects on adverse effects, social outcomes, openness, and mindfulness as well as between-group effects on behavior were not robust against publication bias.</p></div><div id="S29" class="sec sec-last"><h3 id="S29title">Additional Analyses</h3><p id="P33" class="p p-first">Due to insufficient studies, not all moderators could be tested for all models (see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 7</a>). Clinical samples were associated with larger improvements for some comparisons in the domains of negative affect, positive affect, adverse effects, existential/spiritual outcomes, and extraversion. Psychedelic type did not moderate effects, with the exception of within-group pre-post effects on mindfulness for which psilocybin produced larger increases. Presence of behavioral support did not moderate effects. Percentage female did not moderate effects, with the exception within-group pre-follow-up effects on extraversion for which higher percentage female was associated with smaller increases.</p><p id="P34" class="p p-last">Models with outliers removed are reported in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Materials Table 8</a>. No significance tests changed as a result of this and effect sizes were similar in magnitude (change in <em>g</em>&#x02264;0.26).</p></div></div><div id="S30" class="tsec sec"><h2 class="head no_bottom_margin" id="S30title">Discussion</h2><p id="P35" class="p p-first">To our knowledge, this is the first comprehensive meta-analysis of experimental studies testing the post-acute effects of psychedelics.<sup><sup><a href="#FN2" rid="FN2" class=" fn">1</a></sup></sup> Although based on a relatively small number of studies and participants (<em>k</em>=34 studies and 24 unique samples, <em>n</em>=549), results suggest psychedelics may produce beneficial effects. Most relevant for psychiatric samples, large and statistically significant effects were detected for targeted symptoms (<em>g</em>=1.08) when psychedelics were compared with placebo controls in RCTs. As points of comparison, this effect is on par or larger than that achieved by psychotherapy relative to waitlist (e.g., <em>d</em>=0.80; <a href="#R80" rid="R80" class=" bibr popnode">Wampold &#x00026; Imel, 2015</a>) and antidepressants relative to placebo (e.g., <em>d</em>s=0.42 to 0.17; <a href="#R16" rid="R16" class=" bibr popnode">Cipriani et al., 2018</a>). Moreover, this effect appears robust to publication bias and not influenced by outliers. Psychedelics also compared favorably with placebo controls on measures related to negative and positive affect; on measures of social, behavior, and existential/spiritual outcomes; and on depression in samples with depression (although effect on behavior was not robust to fail-safe N). The superiority over placebo controls supports the possibility of specific effects, however this conclusion is necessarily uncertain given difficultly blinding psychedelics. Within-group effects were similar in magnitude and statistical significance, and support the notion that beneficial effects may persist at follow-up. Although adverse effects were not available for 20.8% studies, effects reported were transient and no serious adverse events occurred. Quantitative assessment of longer-term adverse effects similarly suggests that transient psychological effects do not typically remain elevated during the post-acute period and may even reduce in some instances. Evidence supporting the effects of psychedelics on personality and mindfulness were less compelling and less robust to test of publication bias.</p><p id="P36">Due to the limited number of studies and variation across studies in design features, we were limited in our ability to test moderators. Nonetheless, it appears that some effects may be larger for clinical samples. Psychedelic type, presence of behavioral support, and percentage female generally did not moderate effects, although confounding with other design characteristics (e.g., amount of behavioral support, clinical sample) makes these null findings tenuous. It does appear that moderate to large reductions in psychiatric symptoms have been achieved in studies testing psilocybin with relatively little behavioral support (e.g., one to three sessions; Carhart-Harris et al., 2018; Grob et al., 2011). Future clinical trials and meta-analyses should clarify the requisite dosage of behavioral support.</p><p id="P37">Although the most comprehensive quantitative review to date, our study remained limited in sample size and associated statistical power. Indeed, the sample available in the entire literature reviewed (<em>n</em>=549) is considerably smaller than that from large-scale RCTs (e.g., <em>n</em>=952 in Project MATCH; <a href="#R56" rid="R56" class=" bibr popnode">Project Match Research Group, 1998</a>). This highlights the inherent uncertainty in conclusions drawn. An additional complication is the degree to which generalizations can be made from the individuals who chose to participate in the available experimental studies, given psychedelics remain Schedule I substances in most study locations. While selection bias may have produced inflated effect size estimates (e.g., selecting individuals most open to the possibility of change through psychedelic treatments, higher expectancy), some studies included healthy controls with previous use of psychedelics which could have created ceiling effects (i.e., therapeutic effects were achieved at baseline through prior use). A relatively modest amount of racial/ethnic diversity and a lack of reporting on sample race/ethnicity in the available studies is another important limitation that must be addressed (<a href="#R48" rid="R48" class=" bibr popnode">Michaels, Purdon, Collins, &#x00026; Williams, 2018</a>). While we attempted to aggregate effects in conceptually coherent ways, there remained methodological heterogeneity (e.g., psychedelic dose, provision of behavioral support) that was either not modeled or tested in underpowered ways. This makes it impossible to provide recommendations regarding the specific treatment characteristics most strongly linked to beneficial effects. Similarly, although results generally did not change when accounting for publication bias, trim-and-fill analyses were also likely underpowered.</p><p id="P38">A broader potentially more pernicious limitation is risk of bias within the available studies. As noted, obviously psychoactive substances may be particularly difficult to adequately double blind. However, several studies included features that may increase the strength of the placebo condition (e.g., using methylphenidate or other psychoactive agents, making specific treatment conditions and study aims ambiguous; <a href="#R30" rid="R30" class=" bibr popnode">Griffiths et al., 2006</a>). Two potential sources of bias that would be relatively straightforward to address are risks associated with attrition and selective reporting. None of the included studies explicitly used an intention-to-treat analysis, although this would be a straightforward way to address attrition bias. Of note, studies rated here as low on attrition bias generally had no attrition. Selective reporting could be reduced through more consistent pre-registration of study hypotheses. While several included studies were pre-registered (e.g., <a href="http://clinicaltrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">clinicaltrials.gov</a>), many were not, making it difficult to ascertain the degree to which the reported outcomes were specified <em>a priori</em> versus drawn from a larger number of unpublished outcomes (i.e., increasing risk for opportunistic bias; <a href="#R19" rid="R19" class=" bibr popnode">DeCoster, Sparks, Sparks, Sparks, &#x00026; Sparks, 2015</a>). It did not appear that any of the included studies published their hypotheses using the Open Science Framework or similar platforms (e.g., <a href="http://AsPredicted.Org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AsPredicted.Org</a>). While perhaps unsurprising given these platforms are relatively new (<a href="#R22" rid="R22" class=" bibr popnode">Foster &#x00026; Deardorff, 2017</a>) and some contemporary research on psychedelics has been exploratory in nature and may not have had <em>a priori</em> hypotheses, explicit pre-registration of study hypotheses and analysis plans could help reduce selective reporting bias and increase confidence in this body of literature.</p><p id="P39">These limitations notwithstanding, the current study joins the two previous meta-analyses (<a href="#R41" rid="R41" class=" bibr popnode">Krebs &#x00026; Johansen, 2012</a>; <a href="#R25" rid="R25" class=" bibr popnode">Goldberg et al., 2020</a>) suggesting that psychedelics are a class of substances worthy of further exploration.<sup><sup><a href="#FN3" rid="FN3" class=" fn">2</a></sup></sup> Careful, large-scale, placebo-controlled RCTs are especially needed to clarify the empirical status for specific clinical conditions (e.g., depression) as well as for non-clinical applications. Particularly promising applications may include the use of psilocybin for the treatment of anxiety and depression (<a href="#R25" rid="R25" class=" bibr popnode">Goldberg et al., 2020</a>), although ayahuasca and LSD may also prove beneficial for these indications. While based on only one study each in the contemporary period, the use of psilocybin for smoking cessation and LSD for alcohol use are also promising avenues for future exploration, given the prevalence, health burden, and recalcitrance associated with both nicotine and alcohol use disorders. Future studies could pursue the pairing of psychedelics with behavioral interventions and non-psychotherapeutic approaches (e.g., meditation retreats; <a href="#R71" rid="R71" class=" bibr popnode">Smigielski et al., 2019b</a>) to enhance well-being and support flourishing in both clinical and non-clinical samples.</p><p id="P40" class="p p-last">However, it is crucial that future work investigating clinical and non-clinical applications of psychedelics carefully evaluate adverse effects. While we found no clear evidence of persistent adverse effects, many of the included studies excluded individuals with personal or family histories of psychiatric conditions (e.g., bipolar disorder, psychotic disorders). Future studies using alternative designs (e.g., naturalistic and population-based surveys, case reports); extending long-term follow-up to measure protracted effects and naturalistic use in trial participants; and examining safety in previously excluded samples (e.g., contraindicated family histories; personality disorder) may help clarify potential risks.</p></div><div id="SM1" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="SM1title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d40e820"><a href="/pmc/articles/PMC7855004/bin/NIHMS1635180-supplement-1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(269K, pdf)</sup></div></div></div><div id="S31" class="tsec sec"><h2 class="head no_bottom_margin" id="S31title">Acknowledgements</h2><div class="sec"><p id="P41">We are grateful to Drs. Harriet de Wit, Frederick Barrett, Gitte Knudsen, and Rafael dos Santos for sharing data from their studies. We are grateful to Dr. Brian Pace for his comments on study design.</p><p id="P42">Funding Statement</p><p id="P43">Research reported in this publication was supported by the National Center for Complementary &#x00026; Integrative Health of the National Institutes of Health under Award Number K23AT010879 (SG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p></div></div><div id="fn-group-1" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-1title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"><p id="P44" class="p p-first">Conflicts of Interest</p><p id="P45" class="p p-last">In the prior 12 months, Charles L. Raison has served as a consultant for Usona Institute, Alkermes and Shire. All other authors declare that there is no conflict of interest.</p></p><p class="fn sec" id="FN2"><sup>1</sup>Since the time of submission, <a href="#R43" rid="R43" class=" bibr popnode">Luoma et al. (in press)</a> published a meta-analysis of nine placebo-controlled RCTs that was restricted to primary outcomes and included trials testing MDMA.</p><p class="fn sec" id="FN3"><sup>2</sup>Since the time of submission, <a href="#R60" rid="R60" class=" bibr popnode">Romeo et al. (in press)</a> published a meta-analysis of eight studies focused on the effects of classical psychedelics on depression symptoms.</p></div></div><div id="ref-list-1" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-1title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R1"><span class="mixed-citation">Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, &#x00026; Davis AK (2020). <span class="ref-title">Long-term effects of psychedelic drugs: A systematic review</span>. <span class="ref-journal">Neuroscience &#x00026; Biobehavioral Reviews</span>, <span class="ref-vol">113</span>, 179&#x02013;189. doi: 10.1016/j.neubiorev.2020.03.017 [<a href="https://pubmed.ncbi.nlm.nih.gov/32194129" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neubiorev.2020.03.017" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience+&#x00026;+Biobehavioral+Reviews&amp;title=Long-term+effects+of+psychedelic+drugs:+A+systematic+review&amp;author=JS+Aday&amp;author=CM+Mitzkovitz&amp;author=EK+Bloesch&amp;author=CC+Davoli&amp;author=AK+Davis&amp;volume=113&amp;publication_year=2020&amp;pages=179-189&amp;pmid=32194129&amp;doi=10.1016/j.neubiorev.2020.03.017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R2"><span class="mixed-citation">Barrett FS, Doss MK, Sepeda ND, Pekar JJ, &#x00026; Griffiths RR (2020). <span class="ref-title">Emotions and brain function are altered up to one month after a single high dose of psilocybin</span>. <span class="ref-journal">Scientific Reports</span>, <span class="ref-vol">10</span>(<span class="ref-iss">1</span>), 1&#x02013;14. doi: 10.1038/s41598-020-59282-y <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7010702/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32042038" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-020-59282-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scientific+Reports&amp;title=Emotions+and+brain+function+are+altered+up+to+one+month+after+a+single+high+dose+of+psilocybin&amp;author=FS+Barrett&amp;author=MK+Doss&amp;author=ND+Sepeda&amp;author=JJ+Pekar&amp;author=RR+Griffiths&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=1-14&amp;pmid=31913322&amp;doi=10.1038/s41598-020-59282-y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R3"><span class="mixed-citation">Becker B (1988). <span class="ref-title">Synthesizing standardized mean-change measures</span>. <span class="ref-journal">British Journal of Mathematical and Statistical Psychology</span>, <span class="ref-vol">41</span>, 257&#x02013;278. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=British+Journal+of+Mathematical+and+Statistical+Psychology&amp;title=Synthesizing+standardized+mean-change+measures&amp;author=B+Becker&amp;volume=41&amp;publication_year=1988&amp;pages=257-278&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R4"><span class="mixed-citation">Bershad AK, Schepers ST, Bremmer MP, Lee R, &#x00026; de Wit H (2019). <span class="ref-title">Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers</span>. <span class="ref-journal">Biological Psychiatry</span>, <span class="ref-vol">86</span>(<span class="ref-iss">10</span>), 792&#x02013;800. doi: 10.1016/j.biopsych.2019.05.019 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6814527/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31331617" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.biopsych.2019.05.019" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biological+Psychiatry&amp;title=Acute+subjective+and+behavioral+effects+of+microdoses+of+lysergic+acid+diethylamide+in+healthy+human+volunteers&amp;author=AK+Bershad&amp;author=ST+Schepers&amp;author=MP+Bremmer&amp;author=R+Lee&amp;author=H+de+Wit&amp;volume=86&amp;issue=10&amp;publication_year=2019&amp;pages=792-800&amp;pmid=31331617&amp;doi=10.1016/j.biopsych.2019.05.019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R5"><span class="mixed-citation">Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PCR, &#x00026; Strassman RJ (2015). <span class="ref-title">Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">29</span>(<span class="ref-iss">3</span>), 289&#x02013;299. doi: 10.1177/0269881114565144 [<a href="https://pubmed.ncbi.nlm.nih.gov/25586396" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881114565144" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Psilocybin-assisted+treatment+for+alcohol+dependence:+a+proof-of-concept+study&amp;author=MP+Bogenschutz&amp;author=AA+Forcehimes&amp;author=JA+Pommy&amp;author=CE+Wilcox&amp;author=PCR+Barbosa&amp;volume=29&amp;issue=3&amp;publication_year=2015&amp;pages=289-299&amp;pmid=25586396&amp;doi=10.1177/0269881114565144&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R6"><span class="mixed-citation">Bonson KR (2018). <span class="ref-title">Regulation of human research with LSD in the United States (1949&#x02013;1987)</span>. <span class="ref-journal">Psychopharmacology</span>, <span class="ref-vol">235</span>(<span class="ref-iss">2</span>), 591&#x02013;604. doi: 10.1007/s00213-017-4777-4 [<a href="https://pubmed.ncbi.nlm.nih.gov/29147729" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00213-017-4777-4" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Regulation+of+human+research+with+LSD+in+the+United+States+(1949&#x02013;1987)&amp;author=KR+Bonson&amp;volume=235&amp;issue=2&amp;publication_year=2018&amp;pages=591-604&amp;pmid=29147729&amp;doi=10.1007/s00213-017-4777-4&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R7"><span class="mixed-citation">Bouso JC, dos Santos RG, Alc&#x000e1;zar-C&#x000f3;rcoles M&#x000c1;, &#x00026; Hallak JE (2018). <span class="ref-title">Serotonergic psychedelics and personality: A systematic review of contemporary research. <em>Neuroscience &#x00026;</em></span>
<span class="ref-journal">Biobehavioral Reviews</span>, <span class="ref-vol">87</span>, 118&#x02013;132. doi: 10.1016/j.neubiorev.2018.02.004 [<a href="https://pubmed.ncbi.nlm.nih.gov/29452127" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neubiorev.2018.02.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biobehavioral+Reviews&amp;title=Serotonergic+psychedelics+and+personality:+A+systematic+review+of+contemporary+research.+Neuroscience+&#x00026;&amp;author=JC+Bouso&amp;author=RG+dos+Santos&amp;author=M&#x000c1;+Alc&#x000e1;zar-C&#x000f3;rcoles&amp;author=JE+Hallak&amp;volume=87&amp;publication_year=2018&amp;pages=118-132&amp;doi=10.1016/j.neubiorev.2018.02.004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R8"><span class="mixed-citation">Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, &#x02026; &#x00026; Mash DC (1999). <span class="ref-title">Pharmacokinetics of Hoasca alkaloids in healthy humans</span>. <span class="ref-journal">Journal of Ethnopharmacology</span>, <span class="ref-vol">65</span>(<span class="ref-iss">3</span>), 243&#x02013;256. [<a href="https://pubmed.ncbi.nlm.nih.gov/10404423" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Ethnopharmacology&amp;title=Pharmacokinetics+of+Hoasca+alkaloids+in+healthy+humans&amp;author=JC+Callaway&amp;author=DJ+McKenna&amp;author=CS+Grob&amp;author=GS+Brito&amp;author=LP+Raymon&amp;volume=65&amp;issue=3&amp;publication_year=1999&amp;pages=243-256&amp;pmid=10404423&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R9"><span class="mixed-citation">Carhart-Harris RL (2019). <span class="ref-title">How do psychedelics work?</span>
<span class="ref-journal">Current Opinion in Psychiatry</span>, <span class="ref-vol">32</span>(<span class="ref-iss">1</span>), 16&#x02013;21. doi: 10.1097/YCO.0000000000000467 [<a href="https://pubmed.ncbi.nlm.nih.gov/30394903" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2FYCO.0000000000000467" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Opinion+in+Psychiatry&amp;title=How+do+psychedelics+work?&amp;author=RL+Carhart-Harris&amp;volume=32&amp;issue=1&amp;publication_year=2019&amp;pages=16-21&amp;pmid=30394903&amp;doi=10.1097/YCO.0000000000000467&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R10"><span class="mixed-citation">Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, &#x02026; &#x00026; Nutt DJ (2018a). <span class="ref-title">Psilocybin with psychological support for treatment-resistant depression: six-month follow-up</span>. <span class="ref-journal">Psychopharmacology</span>, <span class="ref-vol">235</span>(<span class="ref-iss">2</span>), 399&#x02013;408. doi: 10.1007/s00213-017-4771-x <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5813086/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29119217" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00213-017-4771-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Psilocybin+with+psychological+support+for+treatment-resistant+depression:+six-month+follow-up&amp;author=RL+Carhart-Harris&amp;author=M+Bolstridge&amp;author=CMJ+Day&amp;author=J+Rucker&amp;author=R+Watts&amp;volume=235&amp;issue=2&amp;publication_year=2018a&amp;pages=399-408&amp;pmid=29119217&amp;doi=10.1007/s00213-017-4771-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R11"><span class="mixed-citation">Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, &#x02026; &#x00026; Nutt DJ (2016a). <span class="ref-title">Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study</span>. <span class="ref-journal">The Lancet Psychiatry</span>, <span class="ref-vol">3</span>(<span class="ref-iss">7</span>), 619&#x02013;627. doi: 10.1016/S2215-0366(16)30065-7 [<a href="https://pubmed.ncbi.nlm.nih.gov/27210031" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS2215-0366(16)30065-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Lancet+Psychiatry&amp;title=Psilocybin+with+psychological+support+for+treatment-resistant+depression:+an+open-label+feasibility+study&amp;author=RL+Carhart-Harris&amp;author=M+Bolstridge&amp;author=J+Rucker&amp;author=CM+Day&amp;author=D+Erritzoe&amp;volume=3&amp;issue=7&amp;publication_year=2016a&amp;pages=619-627&amp;pmid=27210031&amp;doi=10.1016/S2215-0366(16)30065-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R12"><span class="mixed-citation">Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, &#x02026; &#x00026; Nutt DJ (2016b). <span class="ref-title">The paradoxical psychological effects of lysergic acid diethylamide (LSD)</span>. <span class="ref-journal">Psychological Medicine</span>, <span class="ref-vol">46</span>(<span class="ref-iss">7</span>), 1379&#x02013;1390. doi: 10.1017/S0033291715002901 [<a href="https://pubmed.ncbi.nlm.nih.gov/26847689" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1017%2FS0033291715002901" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychological+Medicine&amp;title=The+paradoxical+psychological+effects+of+lysergic+acid+diethylamide+(LSD)&amp;author=RL+Carhart-Harris&amp;author=M+Kaelen&amp;author=M+Bolstridge&amp;author=TM+Williams&amp;author=LT+Williams&amp;volume=46&amp;issue=7&amp;publication_year=2016b&amp;pages=1379-1390&amp;pmid=26847689&amp;doi=10.1017/S0033291715002901&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R13"><span class="mixed-citation">Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, &#x02026; &#x00026; Wise RG (2012). <span class="ref-title">Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin</span>. <span class="ref-journal">The British Journal of Psychiatry</span>, <span class="ref-vol">200</span>(<span class="ref-iss">3</span>), 238&#x02013;244. doi: 10.1192/bjp.bp.111.103309 [<a href="https://pubmed.ncbi.nlm.nih.gov/22282432" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1192%2Fbjp.bp.111.103309" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+British+Journal+of+Psychiatry&amp;title=Implications+for+psychedelic-assisted+psychotherapy:+functional+magnetic+resonance+imaging+study+with+psilocybin&amp;author=RL+Carhart-Harris&amp;author=R+Leech&amp;author=TM+Williams&amp;author=D+Erritzoe&amp;author=N+Abbasi&amp;volume=200&amp;issue=3&amp;publication_year=2012&amp;pages=238-244&amp;pmid=22282432&amp;doi=10.1192/bjp.bp.111.103309&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R14"><span class="mixed-citation">Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, &#x00026; Kaelen M (2018b). <span class="ref-title">Psychedelics and the essential importance of context</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">32</span>(<span class="ref-iss">7</span>), 725&#x02013;731. doi: 10.1177/0269881118754710 [<a href="https://pubmed.ncbi.nlm.nih.gov/29446697" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881118754710" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Psychedelics+and+the+essential+importance+of+context&amp;author=RL+Carhart-Harris&amp;author=L+Roseman&amp;author=E+Haijen&amp;author=D+Erritzoe&amp;author=R+Watts&amp;volume=32&amp;issue=7&amp;publication_year=2018b&amp;pages=725-731&amp;pmid=29446697&amp;doi=10.1177/0269881118754710&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R15"><span class="mixed-citation">Cicchetti D (1994). <span class="ref-title">Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology</span>. <span class="ref-journal">Psychological Assessment</span>, <span class="ref-vol">6</span>(<span class="ref-iss">4</span>), 284&#x02013;290. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychological+Assessment&amp;title=Guidelines,+criteria,+and+rules+of+thumb+for+evaluating+normed+and+standardized+assessment+instruments+in+psychology&amp;author=D+Cicchetti&amp;volume=6&amp;issue=4&amp;publication_year=1994&amp;pages=284-290&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R16"><span class="mixed-citation">Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, &#x02026; &#x00026; Geddes JR (2018). <span class="ref-title">Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis</span>. <span class="ref-journal">The Lancet</span>, <span class="ref-vol">391</span>(<span class="ref-iss">10128</span>), 1357&#x02013;1366. doi: 10.1016/S0140-6736(17)32802-7 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5889788/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29477251" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0140-6736(17)32802-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Lancet&amp;title=Comparative+efficacy+and+acceptability+of+21+antidepressant+drugs+for+the+acute+treatment+of+adults+with+major+depressive+disorder:+a+systematic+review+and+network+meta-analysis&amp;author=A+Cipriani&amp;author=TA+Furukawa&amp;author=G+Salanti&amp;author=A+Chaimani&amp;author=LZ+Atkinson&amp;volume=391&amp;issue=10128&amp;publication_year=2018&amp;pages=1357-1366&amp;doi=10.1016/S0140-6736(17)32802-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R17"><span class="mixed-citation">Cohen J (1988). <span class="ref-journal">Statistical power analysis for the behavioral sciences</span> (2nd ed.). Hillsdale, NJ: Erlbaum. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Statistical+power+analysis+for+the+behavioral+sciences&amp;author=J+Cohen&amp;publication_year=1988&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R18"><span class="mixed-citation">Cooper HM, Hedges LV, &#x00026; Valentine JC (2009). <span class="ref-journal">The handbook of research synthesis and meta-analysis</span> (2nd ed.). New York: Russell Sage Foundation. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=The+handbook+of+research+synthesis+and+meta-analysis&amp;author=HM+Cooper&amp;author=LV+Hedges&amp;author=JC+Valentine&amp;publication_year=2009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R19"><span class="mixed-citation">DeCoster J, Sparks EA, Sparks JC, Sparks GG, &#x00026; Sparks CW (2015). <span class="ref-title">Opportunistic biases: Their origins, effects, and an integrated solution</span>. <span class="ref-journal">American Psychologist</span>, <span class="ref-vol">70</span>(<span class="ref-iss">6</span>), 499&#x02013;514. doi: 10.1037/a0039191 [<a href="https://pubmed.ncbi.nlm.nih.gov/26348333" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1037%2Fa0039191" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Psychologist&amp;title=Opportunistic+biases:+Their+origins,+effects,+and+an+integrated+solution&amp;author=J+DeCoster&amp;author=EA+Sparks&amp;author=JC+Sparks&amp;author=GG+Sparks&amp;author=CW+Sparks&amp;volume=70&amp;issue=6&amp;publication_year=2015&amp;pages=499-514&amp;doi=10.1037/a0039191&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R20"><span class="mixed-citation">Del Re AC, Hoyt WT (2014). <span class="ref-journal">MAd: Meta-analysis with mean differences</span>. R package version 0.8&#x02013;2, <a href="http://CRAN.R-project.org/package=MAd" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://CRAN.R-project.org/package=MAd</a></span></li><li id="R21"><span class="mixed-citation">dos Santos RG, Bouso JC, Alc&#x000e1;zar-C&#x000f3;rcoles M&#x000c1;, &#x00026; Hallak JE (2018). <span class="ref-title">Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews</span>. <span class="ref-journal">Expert Review of Clinical Pharmacology</span>, <span class="ref-vol">11</span>(<span class="ref-iss">9</span>), 889&#x02013;902. doi: 10.1080/17512433.2018.1511424 [<a href="https://pubmed.ncbi.nlm.nih.gov/30102078" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F17512433.2018.1511424" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Review+of+Clinical+Pharmacology&amp;title=Efficacy,+tolerability,+and+safety+of+serotonergic+psychedelics+for+the+management+of+mood,+anxiety,+and+substance-use+disorders:+a+systematic+review+of+systematic+reviews&amp;author=RG+dos+Santos&amp;author=JC+Bouso&amp;author=M&#x000c1;+Alc&#x000e1;zar-C&#x000f3;rcoles&amp;author=JE+Hallak&amp;volume=11&amp;issue=9&amp;publication_year=2018&amp;pages=889-902&amp;pmid=30102078&amp;doi=10.1080/17512433.2018.1511424&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R22"><span class="mixed-citation">Foster ED, &#x00026; Deardorff A (2017). <span class="ref-title">Open science framework (OSF)</span>. <span class="ref-journal">Journal of the Medical Library Association</span>, <span class="ref-vol">105</span>(<span class="ref-iss">2</span>), 203&#x02013;206. doi: 10.5195/jmla.2017.88 [<a href="//doi.org/10.5195%2Fjmla.2017.88" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+the+Medical+Library+Association&amp;title=Open+science+framework+(OSF)&amp;author=ED+Foster&amp;author=A+Deardorff&amp;volume=105&amp;issue=2&amp;publication_year=2017&amp;pages=203-206&amp;doi=10.5195/jmla.2017.88&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R23"><span class="mixed-citation">Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, &#x00026; Brenneisen R (2014). <span class="ref-title">Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases</span>. <span class="ref-journal">The Journal of Nervous and Mental Disease</span>, <span class="ref-vol">202</span>(<span class="ref-iss">7</span>), 513&#x02013;520. doi: 10.1097/NMD.0000000000000113 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4086777/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24594678" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2FNMD.0000000000000113" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Nervous+and+Mental+Disease&amp;title=Safety+and+efficacy+of+lysergic+acid+diethylamide-assisted+psychotherapy+for+anxiety+associated+with+life-threatening+diseases&amp;author=P+Gasser&amp;author=D+Holstein&amp;author=Y+Michel&amp;author=R+Doblin&amp;author=B+Yazar-Klosinski&amp;volume=202&amp;issue=7&amp;publication_year=2014&amp;pages=513-520&amp;pmid=24594678&amp;doi=10.1097/NMD.0000000000000113&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R24"><span class="mixed-citation">Giacomelli S, Palmery M, Romanelli L, Cheng CY, &#x00026; Silvestrini B (1998). <span class="ref-title">Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro</span>. <span class="ref-journal">Life Sciences</span>, <span class="ref-vol">63</span>(<span class="ref-iss">3</span>), 215&#x02013;222. [<a href="https://pubmed.ncbi.nlm.nih.gov/9698051" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Life+Sciences&amp;title=Lysergic+acid+diethylamide+(LSD)+is+a+partial+agonist+of+D2+dopaminergic+receptors+and+it+potentiates+dopamine-mediated+prolactin+secretion+in+lactotrophs+in+vitro&amp;author=S+Giacomelli&amp;author=M+Palmery&amp;author=L+Romanelli&amp;author=CY+Cheng&amp;author=B+Silvestrini&amp;volume=63&amp;issue=3&amp;publication_year=1998&amp;pages=215-222&amp;pmid=9698051&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R25"><span class="mixed-citation">Goldberg SB, Pace BT, Nicholas CR, Raison CL, &#x00026; Hutson PR (2020). <span class="ref-title">The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis</span>. <span class="ref-journal">Psychiatry Research</span>, <span class="ref-vol">284</span>, 1&#x02013;4. doi: 10.1016/j.psychres.2020.112749 [<a href="https://pubmed.ncbi.nlm.nih.gov/31931272" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.psychres.2020.112749" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychiatry+Research&amp;title=The+experimental+effects+of+psilocybin+on+symptoms+of+anxiety+and+depression:+A+meta-analysis&amp;author=SB+Goldberg&amp;author=BT+Pace&amp;author=CR+Nicholas&amp;author=CL+Raison&amp;author=PR+Hutson&amp;volume=284&amp;publication_year=2020&amp;pages=1-4&amp;doi=10.1016/j.psychres.2020.112749&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R26"><span class="mixed-citation">Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, &#x02026; &#x00026; Klinedinst MA (2016). <span class="ref-title">Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">30</span>(<span class="ref-iss">12</span>), 1181&#x02013;1197. doi: 10.1177/0269881116675513 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5367557/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27909165" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881116675513" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Psilocybin+produces+substantial+and+sustained+decreases+in+depression+and+anxiety+in+patients+with+life-threatening+cancer:+A+randomized+double-blind+trial&amp;author=RR+Griffiths&amp;author=MW+Johnson&amp;author=MA+Carducci&amp;author=A+Umbricht&amp;author=WA+Richards&amp;volume=30&amp;issue=12&amp;publication_year=2016&amp;pages=1181-1197&amp;pmid=27909165&amp;doi=10.1177/0269881116675513&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R27"><span class="mixed-citation">Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, &#x02026; &#x00026; Klinedinst MA (2018). <span class="ref-title">Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">32</span>(<span class="ref-iss">1</span>), 49&#x02013;69. doi: 10.1177/0269881117731279 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5772431/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29020861" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881117731279" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Psilocybin-occasioned+mystical-type+experience+in+combination+with+meditation+and+other+spiritual+practices+produces+enduring+positive+changes+in+psychological+functioning+and+in+trait+measures+of+prosocial+attitudes+and+behaviors&amp;author=RR+Griffiths&amp;author=MW+Johnson&amp;author=WA+Richards&amp;author=BD+Richards&amp;author=R+Jesse&amp;volume=32&amp;issue=1&amp;publication_year=2018&amp;pages=49-69&amp;pmid=29020861&amp;doi=10.1177/0269881117731279&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R28"><span class="mixed-citation">Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, &#x00026; Jesse R (2011). <span class="ref-title">Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects</span>. <span class="ref-journal">Psychopharmacology</span>, <span class="ref-vol">218</span>(<span class="ref-iss">4</span>), 649&#x02013;665. doi: 10.1007/s00213-011-2358-5 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3308357/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21674151" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00213-011-2358-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Psilocybin+occasioned+mystical-type+experiences:+immediate+and+persisting+dose-related+effects&amp;author=RR+Griffiths&amp;author=MW+Johnson&amp;author=WA+Richards&amp;author=BD+Richards&amp;author=U+McCann&amp;volume=218&amp;issue=4&amp;publication_year=2011&amp;pages=649-665&amp;pmid=21674151&amp;doi=10.1007/s00213-011-2358-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R29"><span class="mixed-citation">Griffiths RR, Richards WA, Johnson MW, McCann UD, &#x00026; Jesse R (2008). <span class="ref-title">Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">22</span>(<span class="ref-iss">6</span>), 621&#x02013;632. doi: 10.1177/0269881108094300 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3050654/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18593735" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881108094300" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Mystical-type+experiences+occasioned+by+psilocybin+mediate+the+attribution+of+personal+meaning+and+spiritual+significance+14+months+later&amp;author=RR+Griffiths&amp;author=WA+Richards&amp;author=MW+Johnson&amp;author=UD+McCann&amp;author=R+Jesse&amp;volume=22&amp;issue=6&amp;publication_year=2008&amp;pages=621-632&amp;pmid=18593735&amp;doi=10.1177/0269881108094300&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R30"><span class="mixed-citation">Griffiths RR, Richards WA, McCann U, &#x00026; Jesse R (2006). <span class="ref-title">Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance</span>. <span class="ref-journal">Psychopharmacology</span>, <span class="ref-vol">187</span>(<span class="ref-iss">3</span>), 268&#x02013;283. doi: 10.1007/s00213-006-0457-5 [<a href="https://pubmed.ncbi.nlm.nih.gov/16826400" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00213-006-0457-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Psilocybin+can+occasion+mystical-type+experiences+having+substantial+and+sustained+personal+meaning+and+spiritual+significance&amp;author=RR+Griffiths&amp;author=WA+Richards&amp;author=U+McCann&amp;author=R+Jesse&amp;volume=187&amp;issue=3&amp;publication_year=2006&amp;pages=268-283&amp;pmid=16826400&amp;doi=10.1007/s00213-006-0457-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R31"><span class="mixed-citation">Guerra-Doce E (2015). <span class="ref-title">Psychoactive substances in prehistoric times: examining the archaeological evidence</span>. <span class="ref-journal">Time and Mind</span>, <span class="ref-vol">8</span>(<span class="ref-iss">1</span>), 91&#x02013;112. doi: 10.1080/1751696X.2014.993244 [<a href="//doi.org/10.1080%2F1751696X.2014.993244" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Time+and+Mind&amp;title=Psychoactive+substances+in+prehistoric+times:+examining+the+archaeological+evidence&amp;author=E+Guerra-Doce&amp;volume=8&amp;issue=1&amp;publication_year=2015&amp;pages=91-112&amp;doi=10.1080/1751696X.2014.993244&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R32"><span class="mixed-citation">Guzm&#x000e1;n G (2008). <span class="ref-title">Hallucinogenic mushrooms in Mexico: An overview</span>. <span class="ref-journal">Economic Botany</span>, <span class="ref-vol">62</span>(<span class="ref-iss">3</span>), 404&#x02013;412. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Economic+Botany&amp;title=Hallucinogenic+mushrooms+in+Mexico:+An+overview&amp;author=G+Guzm&#x000e1;n&amp;volume=62&amp;issue=3&amp;publication_year=2008&amp;pages=404-412&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R33"><span class="mixed-citation">Harrer M, Cuijpers P, Furukawa TA, &#x00026; Ebert DD (2019). <span class="ref-journal">Doing Meta-Analysis in R: A Hands-on Guide</span>. <a href="https://bookdown.org/MathiasHarrer/Doing_Meta_Analysis_in_R/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://bookdown.org/MathiasHarrer/Doing_Meta_Analysis_in_R/</a></span></li><li id="R34"><span class="mixed-citation">Higgins JPT, &#x00026; Green S (2008). <span class="ref-journal">Cochrane Handbook for Systematic Reviews of Interventions</span>. London: John Wiley &#x00026; Sons. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Cochrane+Handbook+for+Systematic+Reviews+of+Interventions&amp;author=JPT+Higgins&amp;author=S+Green&amp;publication_year=2008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R35"><span class="mixed-citation">Higgins JP, Thompson SG, Deeks JJ, &#x00026; Altman DG (2003). <span class="ref-title">Measuring inconsistency in meta-analyses</span>. <span class="ref-journal">BMJ</span>, <span class="ref-vol">327</span>(<span class="ref-iss">7414</span>), 557&#x02013;560. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC192859/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12958120" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Measuring+inconsistency+in+meta-analyses&amp;author=JP+Higgins&amp;author=SG+Thompson&amp;author=JJ+Deeks&amp;author=DG+Altman&amp;volume=327&amp;issue=7414&amp;publication_year=2003&amp;pages=557-560&amp;pmid=12958120&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R36"><span class="mixed-citation">Hofmann A (1980). <span class="ref-journal">LSD: My Problem Child</span>. McGraw-Hill: New York. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=LSD:+My+Problem+Child&amp;author=A+Hofmann&amp;publication_year=1980&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R37"><span class="mixed-citation">Hoyt WT, &#x00026; Del Re AC (2018). <span class="ref-title">Effect size calculation in meta-analyses of psychotherapy outcome research</span>. <span class="ref-journal">Psychotherapy Research</span>, <span class="ref-vol">28</span>, 379&#x02013;388. doi: 10.1080/10503307.2017.1405171 [<a href="https://pubmed.ncbi.nlm.nih.gov/29179665" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F10503307.2017.1405171" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychotherapy+Research&amp;title=Effect+size+calculation+in+meta-analyses+of+psychotherapy+outcome+research&amp;author=WT+Hoyt&amp;author=AC+Del+Re&amp;volume=28&amp;publication_year=2018&amp;pages=379-388&amp;pmid=29179665&amp;doi=10.1080/10503307.2017.1405171&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R38"><span class="mixed-citation">Johnson MW, Garcia-Romeu A, Cosimano MP, &#x00026; Griffiths RR (2014). <span class="ref-title">Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">28</span>(<span class="ref-iss">11</span>), 983&#x02013;992. doi: 10.1177/0269881114548296 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4286320/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25213996" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881114548296" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Pilot+study+of+the+5-HT2AR+agonist+psilocybin+in+the+treatment+of+tobacco+addiction&amp;author=MW+Johnson&amp;author=A+Garcia-Romeu&amp;author=MP+Cosimano&amp;author=RR+Griffiths&amp;volume=28&amp;issue=11&amp;publication_year=2014&amp;pages=983-992&amp;pmid=25213996&amp;doi=10.1177/0269881114548296&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R39"><span class="mixed-citation">Johnson MW, Garcia-Romeu A, &#x00026; Griffiths RR (2017). <span class="ref-title">Long-term follow-up of psilocybin-facilitated smoking cessation</span>. <span class="ref-journal">American Journal of Drug and Alcohol Abuse</span>, <span class="ref-vol">43</span>(<span class="ref-iss">1</span>), 55&#x02013;60. doi: 10.3109/00952990.2016.1170135 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5641975/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27441452" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3109%2F00952990.2016.1170135" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Drug+and+Alcohol+Abuse&amp;title=Long-term+follow-up+of+psilocybin-facilitated+smoking+cessation&amp;author=MW+Johnson&amp;author=A+Garcia-Romeu&amp;author=RR+Griffiths&amp;volume=43&amp;issue=1&amp;publication_year=2017&amp;pages=55-60&amp;doi=10.3109/00952990.2016.1170135&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R40"><span class="mixed-citation">Jungaberle H, Thal S, Zeuch A, Rougemont-B&#x000fc;cking A, von Heyden M, Aicher H, &#x00026; Scheidegger M (2018). <span class="ref-title">Positive psychology in the investigation of psychedelics and entactogens: A critical review</span>. <span class="ref-journal">Neuropharmacology</span>, <span class="ref-vol">142</span>, 179&#x02013;199. doi: 10.1016/j.neuropharm.2018.06.034 [<a href="https://pubmed.ncbi.nlm.nih.gov/29964094" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neuropharm.2018.06.034" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Positive+psychology+in+the+investigation+of+psychedelics+and+entactogens:+A+critical+review&amp;author=H+Jungaberle&amp;author=S+Thal&amp;author=A+Zeuch&amp;author=A+Rougemont-B&#x000fc;cking&amp;author=M+von+Heyden&amp;volume=142&amp;publication_year=2018&amp;pages=179-199&amp;pmid=29964094&amp;doi=10.1016/j.neuropharm.2018.06.034&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R41"><span class="mixed-citation">Krebs TS, &#x00026; Johansen P&#x000d8; (2012). <span class="ref-title">Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">26</span>(<span class="ref-iss">7</span>), 994&#x02013;1002. doi: 10.1177/0269881112439253 [<a href="https://pubmed.ncbi.nlm.nih.gov/22406913" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881112439253" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Lysergic+acid+diethylamide+(LSD)+for+alcoholism:+meta-analysis+of+randomized+controlled+trials&amp;author=TS+Krebs&amp;author=P&#x000d8;+Johansen&amp;volume=26&amp;issue=7&amp;publication_year=2012&amp;pages=994-1002&amp;pmid=22406913&amp;doi=10.1177/0269881112439253&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R42"><span class="mixed-citation">Lovibond SH &#x00026; Lovibond PF (1995). <span class="ref-journal">Manual for the Depression Anxiety Stress Scales</span> (2nd. ed.). Sydney, Australia: Psychology Foundation. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Manual+for+the+Depression+Anxiety+Stress+Scales&amp;author=SH+Lovibond&amp;author=PF+Lovibond&amp;publication_year=1995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R43"><span class="mixed-citation">Luoma JB, Chwyl C, Bathje GJ, Davis AK, &#x00026; Lancelotta R (in press). <span class="ref-title">A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy</span>. <span class="ref-journal">Journal of Psychoactive Drugs</span>. doi: 10.1080/02791072.2020.1769878 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7736164/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32529966" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F02791072.2020.1769878" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychoactive+Drugs&amp;title=A+meta-analysis+of+placebo-controlled+trials+of+psychedelic-assisted+therapy&amp;author=JB+Luoma&amp;author=C+Chwyl&amp;author=GJ+Bathje&amp;author=AK+Davis&amp;author=R+Lancelotta&amp;doi=10.1080/02791072.2020.1769878&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R44"><span class="mixed-citation">Lyons T, &#x00026; Carhart-Harris RL (2018a). <span class="ref-title">Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">32</span>(<span class="ref-iss">7</span>), 811&#x02013;819. doi: 10.1177/0269881117748902 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6047302/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29338538" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881117748902" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Increased+nature+relatedness+and+decreased+authoritarian+political+views+after+psilocybin+for+treatment-resistant+depression&amp;author=T+Lyons&amp;author=RL+Carhart-Harris&amp;volume=32&amp;issue=7&amp;publication_year=2018a&amp;pages=811-819&amp;pmid=29338538&amp;doi=10.1177/0269881117748902&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R45"><span class="mixed-citation">Lyons T, &#x00026; Carhart-Harris RL (2018b). <span class="ref-title">More realistic forecasting of future life events after psilocybin for treatment-resistant depression</span>. <span class="ref-journal">Frontiers in Psychology</span>, <span class="ref-vol">9</span>, 1721. doi: 10.3389/fpsyg.2018.01721 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6194345/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30369890" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffpsyg.2018.01721" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers+in+Psychology&amp;title=More+realistic+forecasting+of+future+life+events+after+psilocybin+for+treatment-resistant+depression&amp;author=T+Lyons&amp;author=RL+Carhart-Harris&amp;volume=9&amp;publication_year=2018b&amp;pages=1721&amp;pmid=30369890&amp;doi=10.3389/fpsyg.2018.01721&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R46"><span class="mixed-citation">MacLean KA, Johnson MW, &#x00026; Griffiths RR (2011). <span class="ref-title">Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">25</span>(<span class="ref-iss">11</span>), 1453&#x02013;1461. doi: 10.1177/0269881111420188 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3537171/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21956378" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881111420188" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Mystical+experiences+occasioned+by+the+hallucinogen+psilocybin+lead+to+increases+in+the+personality+domain+of+openness&amp;author=KA+MacLean&amp;author=MW+Johnson&amp;author=RR+Griffiths&amp;volume=25&amp;issue=11&amp;publication_year=2011&amp;pages=1453-1461&amp;pmid=21956378&amp;doi=10.1177/0269881111420188&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R47"><span class="mixed-citation">McKenna DJ (2004). <span class="ref-title">Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges</span>. <span class="ref-journal">Pharmacology &#x00026; Therapeutics</span>, <span class="ref-vol">102</span>(<span class="ref-iss">2</span>), 111&#x02013;129. [<a href="https://pubmed.ncbi.nlm.nih.gov/15163593" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology+&#x00026;+Therapeutics&amp;title=Clinical+investigations+of+the+therapeutic+potential+of+ayahuasca:+rationale+and+regulatory+challenges&amp;author=DJ+McKenna&amp;volume=102&amp;issue=2&amp;publication_year=2004&amp;pages=111-129&amp;pmid=15163593&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R48"><span class="mixed-citation">Michaels TI, Purdon J, Collins A, &#x00026; Williams MT (2018). <span class="ref-title">Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature</span>. <span class="ref-journal">BMC Psychiatry</span>, <span class="ref-vol">18</span>(<span class="ref-iss">1</span>), 245. doi: 10.1186/s12888-018-1824-6 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6069717/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30064392" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12888-018-1824-6" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Psychiatry&amp;title=Inclusion+of+people+of+color+in+psychedelic-assisted+psychotherapy:+A+review+of+the+literature&amp;author=TI+Michaels&amp;author=J+Purdon&amp;author=A+Collins&amp;author=MT+Williams&amp;volume=18&amp;issue=1&amp;publication_year=2018&amp;pages=245&amp;pmid=30064392&amp;doi=10.1186/s12888-018-1824-6&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R49"><span class="mixed-citation">Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group (2009). <span class="ref-title">Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</span>. <span class="ref-journal">Annals of Internal Medicine</span>, <span class="ref-vol">151</span>(<span class="ref-iss">4</span>), 264&#x02013;269. [<a href="https://pubmed.ncbi.nlm.nih.gov/19622511" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+Internal+Medicine&amp;title=Preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+The+PRISMA+statement&amp;author=D+Moher&amp;author=A+Liberati&amp;author=J+Tetzlaff&amp;author=DG+Altman&amp;volume=151&amp;issue=4&amp;publication_year=2009&amp;pages=264-269&amp;pmid=19622511&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R50"><span class="mixed-citation">Muttoni S, Ardissino M, &#x00026; John C (2019). <span class="ref-title">Classical psychedelics for the treatment of depression and anxiety: a systematic review</span>. <span class="ref-journal">Journal of Affective Disorders</span>, <span class="ref-vol">258</span>, 11&#x02013;24. doi: 10.1016/j.jad.2019.07.076 [<a href="https://pubmed.ncbi.nlm.nih.gov/31382100" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jad.2019.07.076" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Affective+Disorders&amp;title=Classical+psychedelics+for+the+treatment+of+depression+and+anxiety:+a+systematic+review&amp;author=S+Muttoni&amp;author=M+Ardissino&amp;author=C+John&amp;volume=258&amp;publication_year=2019&amp;pages=11-24&amp;pmid=31382100&amp;doi=10.1016/j.jad.2019.07.076&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R51"><span class="mixed-citation">Nicholas CR, Henriquez KM, Gassman MC, Cooper KM, Muller D, Hetzel S, &#x02026; &#x00026; Hutson PR (2018). <span class="ref-title">High dose psilocybin is associated with positive subjective effects in healthy volunteers</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">32</span>(<span class="ref-iss">7</span>), 770&#x02013;778. doi: 10.1177/0269881118780713 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7751062/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29945469" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881118780713" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=High+dose+psilocybin+is+associated+with+positive+subjective+effects+in+healthy+volunteers&amp;author=CR+Nicholas&amp;author=KM+Henriquez&amp;author=MC+Gassman&amp;author=KM+Cooper&amp;author=D+Muller&amp;volume=32&amp;issue=7&amp;publication_year=2018&amp;pages=770-778&amp;pmid=29945469&amp;doi=10.1177/0269881118780713&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R52"><span class="mixed-citation">Nutt DJ, King LA, &#x00026; Nichols DE (2013). <span class="ref-title">Effects of Schedule I drug laws on neuroscience research and treatment innovation</span>. <span class="ref-journal">Nature Reviews Neuroscience</span>, <span class="ref-vol">14</span>(<span class="ref-iss">8</span>), 577&#x02013;585. [<a href="https://pubmed.ncbi.nlm.nih.gov/23756634" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Reviews+Neuroscience&amp;title=Effects+of+Schedule+I+drug+laws+on+neuroscience+research+and+treatment+innovation&amp;author=DJ+Nutt&amp;author=LA+King&amp;author=DE+Nichols&amp;volume=14&amp;issue=8&amp;publication_year=2013&amp;pages=577-585&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R53"><span class="mixed-citation">Ott J (1999). <span class="ref-title">Pharmahuasca: human pharmacology of oral DMT plus harmine</span>. <span class="ref-journal">Journal of Psychoactive Drugs</span>, <span class="ref-vol">31</span>(<span class="ref-iss">2</span>), 171&#x02013;177. [<a href="https://pubmed.ncbi.nlm.nih.gov/10438001" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychoactive+Drugs&amp;title=Pharmahuasca:+human+pharmacology+of+oral+DMT+plus+harmine&amp;author=J+Ott&amp;volume=31&amp;issue=2&amp;publication_year=1999&amp;pages=171-177&amp;pmid=10438001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R54"><span class="mixed-citation">Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, &#x02026; &#x00026; T&#x000f3;foli LF (2019). <span class="ref-title">Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial</span>. <span class="ref-journal">Psychological Medicine</span>, <span class="ref-vol">49</span>(<span class="ref-iss">4</span>), 655&#x02013;663. doi: 10.1017/S0033291718001356 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6378413/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29903051" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1017%2FS0033291718001356" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychological+Medicine&amp;title=Rapid+antidepressant+effects+of+the+psychedelic+ayahuasca+in+treatment-resistant+depression:+a+randomized+placebo-controlled+trial&amp;author=F+Palhano-Fontes&amp;author=D+Barreto&amp;author=H+Onias&amp;author=KC+Andrade&amp;author=MM+Novaes&amp;volume=49&amp;issue=4&amp;publication_year=2019&amp;pages=655-663&amp;pmid=29903051&amp;doi=10.1017/S0033291718001356&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R55"><span class="mixed-citation">Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, St&#x000e4;mpfli P, &#x02026; &#x00026; Vollenweider FX (2017). <span class="ref-title">The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation</span>. <span class="ref-journal">Current Biology</span>, <span class="ref-vol">27</span>(<span class="ref-iss">3</span>), 451&#x02013;457. doi: 10.1016/j.cub.2016.12.030 [<a href="https://pubmed.ncbi.nlm.nih.gov/28132813" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cub.2016.12.030" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Biology&amp;title=The+fabric+of+meaning+and+subjective+effects+in+LSD-induced+states+depend+on+serotonin+2A+receptor+activation&amp;author=KH+Preller&amp;author=M+Herdener&amp;author=T+Pokorny&amp;author=A+Planzer&amp;author=R+Kraehenmann&amp;volume=27&amp;issue=3&amp;publication_year=2017&amp;pages=451-457&amp;pmid=28132813&amp;doi=10.1016/j.cub.2016.12.030&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R56"><span class="mixed-citation">Project MATCH Research Group. (1998). <span class="ref-title">Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes</span>. <span class="ref-journal">Alcoholism: Clinical and Experimental Research</span>, <span class="ref-vol">22</span>(<span class="ref-iss">6</span>), 1300&#x02013;1311. [<a href="https://pubmed.ncbi.nlm.nih.gov/9756046" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Alcoholism:+Clinical+and+Experimental+Research&amp;title=Matching+alcoholism+treatments+to+client+heterogeneity:+Project+MATCH+three-year+drinking+outcomes&amp;volume=22&amp;issue=6&amp;publication_year=1998&amp;pages=1300-1311&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R57"><span class="mixed-citation">R Core Team (2018). <span class="ref-journal">R: A language and environment for statistical computing</span>. R Foundation for Statistical Computing, Vienna, Austria: 
URL <a href="https://www.R-project.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.R-project.org/</a> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=R:+A+language+and+environment+for+statistical+computing&amp;publication_year=2018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R58"><span class="mixed-citation">Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, &#x00026; Maji&#x00107; T (2018). <span class="ref-title">Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review</span>. <span class="ref-journal">Progress in Neuropsychopharmacology &#x00026; Biological Psychiatry</span>, <span class="ref-vol">81</span>, 1&#x02013;10. doi: 10.1016/j.pnpbp.2017.09.012 [<a href="https://pubmed.ncbi.nlm.nih.gov/28947181" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.pnpbp.2017.09.012" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Progress+in+Neuropsychopharmacology+&#x00026;+Biological+Psychiatry&amp;title=Serotonergic+hallucinogens+in+the+treatment+of+anxiety+and+depression+in+patients+suffering+from+a+life-threatening+disease:+A+systematic+review&amp;author=S+Reiche&amp;author=L+Hermle&amp;author=S+Gutwinski&amp;author=H+Jungaberle&amp;author=P+Gasser&amp;volume=81&amp;publication_year=2018&amp;pages=1-10&amp;doi=10.1016/j.pnpbp.2017.09.012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R59"><span class="mixed-citation">Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, &#x02026; &#x00026; Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. (2020). <span class="ref-title">Psychedelics and psychedelic-assisted psychotherapy</span>. <span class="ref-journal">American Journal of Psychiatry</span>, <span class="ref-vol">177</span>, 391&#x02013;410. doi: 10.1176/appi.ajp.2019.19010035 [<a href="https://pubmed.ncbi.nlm.nih.gov/32098487" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1176%2Fappi.ajp.2019.19010035" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Psychiatry&amp;title=Psychedelics+and+psychedelic-assisted+psychotherapy&amp;author=CM+Reiff&amp;author=EE+Richman&amp;author=CB+Nemeroff&amp;author=LL+Carpenter&amp;author=AS+Widge&amp;volume=177&amp;publication_year=2020&amp;pages=391-410&amp;doi=10.1176/appi.ajp.2019.19010035&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R60"><span class="mixed-citation">Romeo B, Karila L, Martelli C, &#x00026; Benyamina A (in press). <span class="ref-title">Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis</span>. <span class="ref-journal">Journal of Psychopharmacology</span>. doi: 10.1177/0269881120919957 [<a href="https://pubmed.ncbi.nlm.nih.gov/32448048" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881120919957" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Efficacy+of+psychedelic+treatments+on+depressive+symptoms:+A+meta-analysis&amp;author=B+Romeo&amp;author=L+Karila&amp;author=C+Martelli&amp;author=A+Benyamina&amp;doi=10.1177/0269881120919957&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R61"><span class="mixed-citation">Rosenberg MS (2005). <span class="ref-title">The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis</span>. <span class="ref-journal">Evolution</span>, <span class="ref-vol">59</span>(<span class="ref-iss">2</span>), 464&#x02013;468. [<a href="https://pubmed.ncbi.nlm.nih.gov/15807430" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Evolution&amp;title=The+file-drawer+problem+revisited:+a+general+weighted+method+for+calculating+fail-safe+numbers+in+meta-analysis&amp;author=MS+Rosenberg&amp;volume=59&amp;issue=2&amp;publication_year=2005&amp;pages=464-468&amp;pmid=15807430&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R62"><span class="mixed-citation">Rosenthal R (1979). <span class="ref-title">The &#x0201c;file drawer problem&#x0201d; and tolerance for null results</span>. <span class="ref-journal">Psychological Bulletin</span>, <span class="ref-vol">86</span>(<span class="ref-iss">3</span>), 638&#x02013;641. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychological+Bulletin&amp;title=The+&#x0201c;file+drawer+problem&#x0201d;+and+tolerance+for+null+results&amp;author=R+Rosenthal&amp;volume=86&amp;issue=3&amp;publication_year=1979&amp;pages=638-641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R63"><span class="mixed-citation">Ross S (2018). <span class="ref-title">Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress</span>. <span class="ref-journal">International Review of Psychiatry</span>, <span class="ref-vol">30</span>(<span class="ref-iss">4</span>), 317&#x02013;330. doi: 10.1080/09540261.2018.1482261 [<a href="https://pubmed.ncbi.nlm.nih.gov/30102082" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F09540261.2018.1482261" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Review+of+Psychiatry&amp;title=Therapeutic+use+of+classic+psychedelics+to+treat+cancer-related+psychiatric+distress&amp;author=S+Ross&amp;volume=30&amp;issue=4&amp;publication_year=2018&amp;pages=317-330&amp;pmid=30102082&amp;doi=10.1080/09540261.2018.1482261&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R64"><span class="mixed-citation">Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, &#x02026; &#x00026; Schmidt BL (2016). <span class="ref-title">Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">30</span>(<span class="ref-iss">12</span>), 1165&#x02013;1180. doi: 10.1177/0269881116675512 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5367551/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27909164" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881116675512" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Rapid+and+sustained+symptom+reduction+following+psilocybin+treatment+for+anxiety+and+depression+in+patients+with+life-threatening+cancer:+a+randomized+controlled+trial&amp;author=S+Ross&amp;author=A+Bossis&amp;author=J+Guss&amp;author=G+Agin-Liebes&amp;author=T+Malone&amp;volume=30&amp;issue=12&amp;publication_year=2016&amp;pages=1165-1180&amp;pmid=27909164&amp;doi=10.1177/0269881116675512&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R65"><span class="mixed-citation">Samorini G (2019). <span class="ref-title">The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview</span>. <span class="ref-journal">Journal of Psychedelic Studies</span>, 1&#x02013;18. doi: 10.1556/2054.2019.008 [<a href="//doi.org/10.1556%2F2054.2019.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychedelic+Studies&amp;title=The+oldest+archeological+data+evidencing+the+relationship+of+Homo+sapiens+with+psychoactive+plants:+A+worldwide+overview&amp;author=G+Samorini&amp;publication_year=2019&amp;pages=1-18&amp;doi=10.1556/2054.2019.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R66"><span class="mixed-citation">Schenberg EE (2018). <span class="ref-title">Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric research and development</span>. <span class="ref-journal">Frontiers in Pharmacology</span>, <span class="ref-vol">9</span>, 733. doi: 10.3389/fphar.2018.00733 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6041963/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30026698" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2018.00733" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers+in+Pharmacology&amp;title=Psychedelic-assisted+psychotherapy:+A+paradigm+shift+in+psychiatric+research+and+development&amp;author=EE+Schenberg&amp;volume=9&amp;publication_year=2018&amp;pages=733&amp;pmid=30026698&amp;doi=10.3389/fphar.2018.00733&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R67"><span class="mixed-citation">Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, &#x02026; &#x00026; Liechti ME (2015). <span class="ref-title">Acute effects of lysergic acid diethylamide in healthy subjects</span>. <span class="ref-journal">Biological Psychiatry</span>, <span class="ref-vol">78</span>(<span class="ref-iss">8</span>), 544&#x02013;553. doi: 10.1016/j.biopsych.2014.11.015 [<a href="https://pubmed.ncbi.nlm.nih.gov/25575620" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.biopsych.2014.11.015" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biological+Psychiatry&amp;title=Acute+effects+of+lysergic+acid+diethylamide+in+healthy+subjects&amp;author=Y+Schmid&amp;author=F+Enzler&amp;author=P+Gasser&amp;author=E+Grouzmann&amp;author=KH+Preller&amp;volume=78&amp;issue=8&amp;publication_year=2015&amp;pages=544-553&amp;pmid=25575620&amp;doi=10.1016/j.biopsych.2014.11.015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R68"><span class="mixed-citation">Schultes RE (1969). <span class="ref-title">Hallucinogens of plant origin</span>. <span class="ref-journal">Science</span>, <span class="ref-vol">163</span>(<span class="ref-iss">3864</span>), 245&#x02013;254. [<a href="https://pubmed.ncbi.nlm.nih.gov/4883616" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Hallucinogens+of+plant+origin&amp;author=RE+Schultes&amp;volume=163&amp;issue=3864&amp;publication_year=1969&amp;pages=245-254&amp;pmid=4883616&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R69"><span class="mixed-citation">Soler J, Elices M, Dominguez-Clav&#x000e9; E, Pascual JC, Feilding A, Navarro-Gil M, &#x02026; &#x00026; Riba J (2018). <span class="ref-title">Four weekly ayahuasca sessions lead to increases in &#x0201c;acceptance&#x0201d; capacities: a comparison study with a standard 8-week mindfulness training program</span>. <span class="ref-journal">Frontiers in Pharmacology</span>, <span class="ref-vol">9</span>, 224. doi: 10.3389/fphar.2018.00224 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5869920/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29615905" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2018.00224" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers+in+Pharmacology&amp;title=Four+weekly+ayahuasca+sessions+lead+to+increases+in+&#x0201c;acceptance&#x0201d;+capacities:+a+comparison+study+with+a+standard+8-week+mindfulness+training+program&amp;author=J+Soler&amp;author=M+Elices&amp;author=E+Dominguez-Clav&#x000e9;&amp;author=JC+Pascual&amp;author=A+Feilding&amp;volume=9&amp;publication_year=2018&amp;pages=224&amp;pmid=29615905&amp;doi=10.3389/fphar.2018.00224&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R70"><span class="mixed-citation">Smigielski L, Kometer M, Scheidegger M, Kr&#x000e4;henmann R, Huber T, &#x00026; Vollenweider FX (2019a). <span class="ref-title">Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat</span>. <span class="ref-journal">Scientific Reports</span>, <span class="ref-vol">9</span>(<span class="ref-iss">1</span>), 1&#x02013;13. doi: 10.1038/s41598-019-50612-3 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6813317/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31649304" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-019-50612-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scientific+Reports&amp;title=Characterization+and+prediction+of+acute+and+sustained+response+to+psychedelic+psilocybin+in+a+mindfulness+group+retreat&amp;author=L+Smigielski&amp;author=M+Kometer&amp;author=M+Scheidegger&amp;author=R+Kr&#x000e4;henmann&amp;author=T+Huber&amp;volume=9&amp;issue=1&amp;publication_year=2019a&amp;pages=1-13&amp;pmid=30626917&amp;doi=10.1038/s41598-019-50612-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R71"><span class="mixed-citation">Smigielski L, Scheidegger M, Kometer M, &#x00026; Vollenweider FX (2019b). <span class="ref-title">Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects</span>. <span class="ref-journal">NeuroImage</span>, <span class="ref-vol">196</span>, 207&#x02013;215. doi: 10.1016/j.neuroimage.2019.04.009 [<a href="https://pubmed.ncbi.nlm.nih.gov/30965131" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.neuroimage.2019.04.009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=NeuroImage&amp;title=Psilocybin-assisted+mindfulness+training+modulates+self-consciousness+and+brain+default+mode+network+connectivity+with+lasting+effects&amp;author=L+Smigielski&amp;author=M+Scheidegger&amp;author=M+Kometer&amp;author=FX+Vollenweider&amp;volume=196&amp;publication_year=2019b&amp;pages=207-215&amp;pmid=30965131&amp;doi=10.1016/j.neuroimage.2019.04.009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R72"><span class="mixed-citation">Strassman RJ, Qualls CR, Uhlenhuth EH, &#x00026; Kellner R (1994). <span class="ref-title">Dose-response study of N, N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale</span>. <span class="ref-journal">Archives of General Psychiatry</span>, <span class="ref-vol">51</span>(<span class="ref-iss">2</span>), 98&#x02013;108. [<a href="https://pubmed.ncbi.nlm.nih.gov/8297217" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Archives+of+General+Psychiatry&amp;title=Dose-response+study+of+N,+N-dimethyltryptamine+in+humans:+II.+Subjective+effects+and+preliminary+results+of+a+new+rating+scale&amp;author=RJ+Strassman&amp;author=CR+Qualls&amp;author=EH+Uhlenhuth&amp;author=R+Kellner&amp;volume=51&amp;issue=2&amp;publication_year=1994&amp;pages=98-108&amp;pmid=8297217&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R73"><span class="mixed-citation">Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, &#x02026; &#x00026; Carhart-Harris RL (2018). <span class="ref-title">Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression</span>. <span class="ref-journal">Psychopharmacology</span>, <span class="ref-vol">235</span>(<span class="ref-iss">2</span>), 459&#x02013;466. doi: 10.1007/s00213-017-4754-y <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5813058/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29085980" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00213-017-4754-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Psilocybin+with+psychological+support+improves+emotional+face+recognition+in+treatment-resistant+depression&amp;author=JB+Stroud&amp;author=TP+Freeman&amp;author=R+Leech&amp;author=C+Hindocha&amp;author=W+Lawn&amp;volume=235&amp;issue=2&amp;publication_year=2018&amp;pages=459-466&amp;pmid=29085980&amp;doi=10.1007/s00213-017-4754-y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R74"><span class="mixed-citation">Studerus E, Gamma A, &#x00026; Vollenweider FX (2010). <span class="ref-title">Psychometric evaluation of the altered states of consciousness rating scale (OAV)</span>. <span class="ref-journal">PloS one</span>, <span class="ref-vol">5</span>(<span class="ref-iss">8</span>). doi: 10.1371/journal.pone.0012412 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2930851/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20824211" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0012412" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PloS+one&amp;title=Psychometric+evaluation+of+the+altered+states+of+consciousness+rating+scale+(OAV)&amp;author=E+Studerus&amp;author=A+Gamma&amp;author=FX+Vollenweider&amp;volume=5&amp;issue=8&amp;publication_year=2010&amp;doi=10.1371/journal.pone.0012412&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R75"><span class="mixed-citation">Studerus E, Kometer M, Hasler F, &#x00026; Vollenweider FX (2011). <span class="ref-title">Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies</span>. <span class="ref-journal">Journal of Psychopharmacology</span>, <span class="ref-vol">25</span>(<span class="ref-iss">11</span>), 1434&#x02013;1452. doi: 10.1177/0269881110382466 [<a href="https://pubmed.ncbi.nlm.nih.gov/20855349" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F0269881110382466" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Psychopharmacology&amp;title=Acute,+subacute+and+long-term+subjective+effects+of+psilocybin+in+healthy+humans:+a+pooled+analysis+of+experimental+studies&amp;author=E+Studerus&amp;author=M+Kometer&amp;author=F+Hasler&amp;author=FX+Vollenweider&amp;volume=25&amp;issue=11&amp;publication_year=2011&amp;pages=1434-1452&amp;pmid=20855349&amp;doi=10.1177/0269881110382466&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R76"><span class="mixed-citation">Valentine JC, Pigott TD, &#x00026; Rothstein HR (2010). <span class="ref-title">How many studies do you need? A primer on statistical power for meta-analysis</span>. <span class="ref-journal">Journal of Educational and Behavioral Statistics</span>, <span class="ref-vol">35</span>(<span class="ref-iss">2</span>), 215&#x02013;247. doi: 10.3102/1076998609346961 [<a href="//doi.org/10.3102%2F1076998609346961" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Educational+and+Behavioral+Statistics&amp;title=How+many+studies+do+you+need?+A+primer+on+statistical+power+for+meta-analysis&amp;author=JC+Valentine&amp;author=TD+Pigott&amp;author=HR+Rothstein&amp;volume=35&amp;issue=2&amp;publication_year=2010&amp;pages=215-247&amp;doi=10.3102/1076998609346961&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R77"><span class="mixed-citation">Viechtbauer W (2010). <span class="ref-title">Conducting meta-analyses in R with the metafor package</span>. <span class="ref-journal">Journal of Statistical Software</span>, <span class="ref-vol">36</span>(<span class="ref-iss">3</span>), 1&#x02013;49. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Statistical+Software&amp;title=Conducting+meta-analyses+in+R+with+the+metafor+package&amp;author=W+Viechtbauer&amp;volume=36&amp;issue=3&amp;publication_year=2010&amp;pages=1-49&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R78"><span class="mixed-citation">Viechtbauer W, &#x00026; Cheung MWL (2010). <span class="ref-title">Outlier and influence diagnostics for meta-analysis</span>. <span class="ref-journal">Research Synthesis Methods</span>, <span class="ref-vol">1</span>(<span class="ref-iss">2</span>), 112&#x02013;125. doi: 10.1002/jrsm.11 [<a href="https://pubmed.ncbi.nlm.nih.gov/26061377" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjrsm.11" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Research+Synthesis+Methods&amp;title=Outlier+and+influence+diagnostics+for+meta-analysis&amp;author=W+Viechtbauer&amp;author=MWL+Cheung&amp;volume=1&amp;issue=2&amp;publication_year=2010&amp;pages=112-125&amp;pmid=26061377&amp;doi=10.1002/jrsm.11&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R79"><span class="mixed-citation">Vollenweider FX, Vollenweider-Scherpenhuyzen MF, B&#x000e4;bler A, Vogel H, &#x00026; Hell D (1998). <span class="ref-title">Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action</span>. <span class="ref-journal">NeuroReport</span>, <span class="ref-vol">9</span>(<span class="ref-iss">17</span>), 3897&#x02013;3902. [<a href="https://pubmed.ncbi.nlm.nih.gov/9875725" ref="reftype=pubmed&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=NeuroReport&amp;title=Psilocybin+induces+schizophrenia-like+psychosis+in+humans+via+a+serotonin-2+agonist+action&amp;author=FX+Vollenweider&amp;author=MF+Vollenweider-Scherpenhuyzen&amp;author=A+B&#x000e4;bler&amp;author=H+Vogel&amp;author=D+Hell&amp;volume=9&amp;issue=17&amp;publication_year=1998&amp;pages=3897-3902&amp;pmid=9875725&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R80"><span class="mixed-citation">Wampold B, &#x00026; Imel ZE (2015). <span class="ref-journal">The great psychotherapy debate: The evidence for what makes psychotherapy work</span> (2nd ed.). New York: Routledge. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=The+great+psychotherapy+debate:+The+evidence+for+what+makes+psychotherapy+work&amp;author=B+Wampold&amp;author=ZE+Imel&amp;publication_year=2015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7855004&amp;issue-id=374551&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pubreader-link other_item"><a href="/pmc/articles/PMC7855004/?report=reader" class="sidefm-pmclink">PubReader</a></li>
<li class="pdf-link other_item"><a href="/pmc/articles/PMC7855004/pdf/nihms-1635180.pdf" class="int-view">PDF (429K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7855004/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7855004/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<div class="collections-button-container" data-article-id="7855004" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7855004%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="DHzYSrE6roowqANOSGwMf1ycnWu5qmxOQKHLAbVMei7hCs3WcccdtuY0J2OaTADS">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7855004%2F&amp;text=Post-acute%20psychological%20effects%20of%20classical%20serotonergic%20psychedelics%3A%20A%20systematic%20review%20and%20meta-analysis" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7855004%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855004/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7855004/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/33143790/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7855004/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/33143790/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7855004/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7855004/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.54110350c77632754ed7.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.586993420cfd.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.bf4d0b9d90eb88f67344.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC7855004/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
